TW201030056A - Liquid crystal aligning agent and liquid crystal display element using same - Google Patents

Liquid crystal aligning agent and liquid crystal display element using same Download PDF

Info

Publication number
TW201030056A
TW201030056A TW98133968A TW98133968A TW201030056A TW 201030056 A TW201030056 A TW 201030056A TW 98133968 A TW98133968 A TW 98133968A TW 98133968 A TW98133968 A TW 98133968A TW 201030056 A TW201030056 A TW 201030056A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
crystal alignment
diamine
formula
treatment agent
Prior art date
Application number
TW98133968A
Other languages
Chinese (zh)
Other versions
TWI454504B (en
Inventor
Takahiro Noda
Takuro Oda
Kimiaki Tsutsui
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW201030056A publication Critical patent/TW201030056A/en
Application granted granted Critical
Publication of TWI454504B publication Critical patent/TWI454504B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1042Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • C08G73/1078Partially aromatic polyimides wholly aromatic in the diamino moiety
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)
  • Furan Compounds (AREA)

Abstract

A liquid crystal aligning agent capable of providing a liquid crystal alignment film which is not susceptible to film separation or chipping during rubbing, has high voltage holding ratio, and does not easily accumulate electrical charges at the initial stage even when a direct current voltage is applied to the liquid crystal cell. The liquid crystal aligning agent contains at least one kind of polymer selected from polyamic acids, each of which is obtained by reacting a diamine component containing a diamine represented by formula [1] with a tetracarboxylic acid dianhydride component, and polyimides obtained by imidizing the polyamic acids. (In the formula, X represents a single bond, an alkylene having 1-3 carbon atoms, -OCH2-, -CH2OCO-, -NHCO-, -CONH- or -COOCH2-; Y represents an oxygen atom or a sulfur atom; and any hydrogen atom in the five-membered ring can be substituted by an alkyl group having 1-5 carbon atoms.)

Description

201030056 六、發明說明 【發明所屬之技術領域】 本發明係有關用於液晶顯示元件之液晶配向處理劑、 液晶配向膜及液晶顯示元件。 【先前技術】 目前,液晶顯示元件之液晶配向膜主要使用塗佈以聚 Φ 醯胺酸等之聚醯亞胺前驅體或可溶性聚醯亞胺之溶液爲主 成分的液晶配向處理劑,經燒成後之所謂的聚醯亞胺系的 液晶配向膜。 液晶配向膜不僅控制液晶之配向狀態,且也影響液晶 顯示元件之特性。特別是隨著液晶顯示元件之高精細化, 因此抑制液晶顯示元件之對比降低及降低殘像顯像等的特 性變得重要。 聚醯亞胺系之液晶配向膜中,因直流電壓產生之殘像 Ο 消失爲止之時間較短者,例如使用除了聚醯胺酸或含有醯 亞胺之聚醯胺酸外,含有特定結構之三級胺之液晶配向處 理劑者(例如參照專利文獻1 ),或使用原料使用具有吡啶 骨架等之特定二胺之含有可溶性聚醯亞胺的液晶配向處理 劑者(例如參照專利文獻2)等已爲人知。 另外,聚醯亞胺系之液晶配向膜中,電壓保持率高, 且因直流電壓產生之殘像消失爲止之時間較短者,例如除 了聚醯胺酸或其醯亞胺化聚合物等外,使用含有極少量之 選自分子內含有1個羧酸基之化合物、分子內含有1個羧 -5- 201030056 酸酐基之化合物及分子內含有1個三級胺基之化合物之化 合物的液晶配向處理劑者(例如參照專利文獻3)已爲人 知。 先前技術文獻 專利文獻 〔專利文獻1〕特開平9-316200號公報 〔專利文獻2〕特開平10-104633號公報 〔專利文獻3〕特開平8 -76 1 28號公報 【發明內容】 [發明之槪要] 〔發明欲解決的課題〕 直到目前爲止,對於液晶面板之殘像顯像的解決方 法,例如有縮短殘像消失爲止的時間,但是僅有此對策仍 是不足。 本發明有鑒於上述狀況,本發明之目的係提供對於摩 擦時之膜剝離或切削耐性強,電壓保持率高,且即使對液 晶胞(liquid crystal cell )施加直流電壓,也不易產生初期 電荷之蓄積之液晶配向膜的液晶配向處理劑。 欲解決的問題的手段 本發明人爲了達成上述目的,而精心硏究的結果,遂 完成本發明。換言之,本發明係具有以下發明要件者。 (υ—種液晶配向處理劑,其特徵係含有選自使含有 201030056 下述式π]之二胺的二胺成分與四羧酸二酐成分反應所得 之聚醯胺酸、及使該聚醯胺酸進行醯亞胺化所得的聚醯亞 胺所成群之至少一種的聚合物, [化1]201030056 VI. Description of the Invention [Technical Field] The present invention relates to a liquid crystal alignment treatment agent, a liquid crystal alignment film, and a liquid crystal display element for use in a liquid crystal display element. [Prior Art] At present, a liquid crystal alignment film of a liquid crystal display element mainly uses a liquid crystal alignment treatment agent which is mainly composed of a solution of a polyfluorene imine or a polyacrylamide precursor such as poly Φ lysine or the like. A so-called polyimine-based liquid crystal alignment film which is formed later. The liquid crystal alignment film not only controls the alignment state of the liquid crystal but also affects the characteristics of the liquid crystal display element. In particular, as the liquid crystal display element is highly refined, it is important to suppress the contrast reduction of the liquid crystal display element and to reduce the characteristics of afterimage development. In the polyimine-based liquid crystal alignment film, the time period until the afterimage of the DC voltage disappears is short, and for example, a polyamine or a polyamido acid containing a quinone is used, and a specific structure is used. (for example, refer to Patent Document 1), or a liquid crystal alignment treatment agent containing a soluble polyimine containing a specific diamine such as a pyridine skeleton (see, for example, Patent Document 2) It is already known. Further, in the polyimine-based liquid crystal alignment film, the voltage holding ratio is high, and the time until the residual image due to the DC voltage disappears is short, for example, in addition to poly-proline or a quinone imidized polymer thereof. Liquid crystal alignment using a compound containing a very small amount of a compound containing one carboxylic acid group in the molecule, a compound containing one carboxy-5-201030056 acid anhydride group in the molecule, and a compound having one tertiary amino group in the molecule The treatment agent (for example, refer to Patent Document 3) is known. CITATION LIST Patent Literature [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. [Immediately] [The problem to be solved by the invention] Up to now, the solution to the afterimage development of the liquid crystal panel has, for example, shortened the time until the afterimage disappears, but this countermeasure is still insufficient. The present invention has been made in view of the above circumstances, and an object of the present invention is to provide film peeling or chip resistance during rubbing, high voltage holding ratio, and low initial voltage accumulation even when a direct current voltage is applied to a liquid crystal cell. A liquid crystal alignment treatment agent for a liquid crystal alignment film. Means for Solving the Problems The inventors of the present invention have completed the present invention in order to achieve the above object. In other words, the present invention has the following inventive requirements. (a liquid crystal alignment treatment agent characterized in that it contains a polyamine acid obtained by reacting a diamine component containing a diamine having the following formula π] of 201030056 with a tetracarboxylic dianhydride component, and the polyfluorene is obtained. a polymer of at least one of a group of polyimines obtained by ruthenium imidization of aminic acid, [Chemical Formula 1]

〇 (式中’X係表示單鍵、碳數爲1〜3之伸烷基、〇 (wherein 'X represents a single bond, an alkylene group having a carbon number of 1 to 3,

-OCH2-、-CH20C0-、-NHCO-、-CONH-、或-COOCH2-,Y 係表示氧原子或硫原子,五員環之任意的氫原子可被碳數 ~ 1~5之烷基取代)。 (2) 如上述(1)項之液晶配向處理劑,其中式[丨]之γ爲 氧原子。 (3) 如上述(1)項之液晶配向處理劑,其中式[〗]之γ爲 硫原子。 ® (4)如上述(1)〜(3)項中任一項之液晶配向處理劑,其 中式[1]之 X 爲-CH2OCO-、-NHCO-、或-COOCH2-。 (5) 如上述(1)項之液晶配向處理劑,其中式[丨]之X 爲-CH2OCO-' -NHCO-、或-COOCH2-,Y 爲氧原子。 (6) 如上述(1)〜(5)項中任一項之液晶配向處理劑,其 中式[1]之五員環之任意的氫原子被甲基取代。 (7) —種液晶配向膜,其特徵係使用如上述(1)〜(6)項 中任一項之液晶配向處理劑所得者。 (8) —種液晶顯示元件,其特徵係具備如上述(7)項之 201030056 液晶配向膜。 (9)一種二胺,其特徵係以下述式[2]表示, [化2]-OCH2-, -CH20C0-, -NHCO-, -CONH-, or -COOCH2-, Y represents an oxygen atom or a sulfur atom, and any hydrogen atom of the five-membered ring may be substituted with an alkyl group of 1 to 5 carbon atoms. ). (2) The liquid crystal alignment treatment agent according to the above item (1), wherein γ of the formula [丨] is an oxygen atom. (3) The liquid crystal alignment treatment agent according to the above item (1), wherein γ of the formula [] is a sulfur atom. The liquid crystal alignment treatment agent according to any one of the above items (1) to (3), wherein X of the formula [1] is -CH2OCO-, -NHCO-, or -COOCH2-. (5) The liquid crystal alignment treatment agent according to the above item (1), wherein X of the formula [丨] is -CH2OCO-'-NHCO- or -COOCH2-, and Y is an oxygen atom. (6) The liquid crystal alignment treatment agent according to any one of the items (1) to (5), wherein any one of the hydrogen atoms of the five-membered ring of the formula [1] is substituted with a methyl group. (7) A liquid crystal alignment film which is obtained by using the liquid crystal alignment treatment agent according to any one of the above (1) to (6). (8) A liquid crystal display element characterized by comprising the 201030056 liquid crystal alignment film of the above (7). (9) A diamine characterized by the following formula [2], [Chemical 2]

(呋喃環之任意的氫原子可被碳數1〜5的烷基取代)。 (10) 如上述(9)項之二胺,其中呋喃環之任意的氫原子 _ 可被甲基取代。 (11) 一種聚醯亞胺’其特徵係使含有如上述(9)或(10) 項之二胺的二胺成分與四羧酸二酐成分反應所得之聚醯胺 酸、或將該聚醯胺酸進行醯亞胺化所得。 ' 發明效果 本發明之液晶配向處理劑可得到對於摩擦時之膜剝離 或切削耐性強,電壓保持率高,且即使對液晶胞施加直流 © 電壓,也不易產生初期電荷蓄積之液晶配向膜,使用此液 晶配向膜可製作特性良好的液晶面板。 實施發明的形態 本發明之液晶配向處理劑,其特徵係含有使含有下述 式[1]之二胺的二胺成分與四羧酸二酐成分反應所得之聚 醯胺酸、及使該聚醯胺酸進行醯亞胺化所得的聚醯亞胺中 之至少一種聚合物的液晶配向處理劑。藉由使用此二胺’ -8 - 201030056 即使在液晶配向處理所必要之摩擦處理時,也可減輕摩擦 時之膜剝離及切削’所得之液晶配向膜爲電壓保持率高, 且即使對液晶胞施加直流電壓,也可不易產生初期電荷蓄 積。 <式[1]之二胺> 式[1 ]表示之二胺的合成法無特別限定,例如可在合 φ 成下述式[S1]表示之二硝基化合物後,再以一般的方法使 硝基還原轉變成胺基的方法來合成。 [化3](Any hydrogen atom of the furan ring may be substituted by an alkyl group having 1 to 5 carbon atoms). (10) The diamine of the above item (9), wherein any hydrogen atom of the furan ring is substituted by a methyl group. (11) A polyimine which is characterized in that the polyamine contained in a diamine component containing the diamine of the above (9) or (10) is reacted with a tetracarboxylic dianhydride component, or the poly The proline acid is obtained by hydrazylation. In the liquid crystal alignment treatment agent of the present invention, it is possible to obtain a liquid crystal alignment film which is excellent in film peeling resistance during cutting, has high cutting resistance, and has a high voltage holding ratio, and which does not easily generate initial charge accumulation even when a DC voltage is applied to the liquid crystal cell. This liquid crystal alignment film can produce a liquid crystal panel having good characteristics. According to the liquid crystal alignment treatment agent of the present invention, the polyamine acid obtained by reacting a diamine component containing a diamine of the following formula [1] with a tetracarboxylic dianhydride component, and the polymerization are contained. The phthalic acid is a liquid crystal alignment treatment agent for at least one of the polyimine obtained by hydrazylation. By using this diamine ' -8 - 201030056, even in the rubbing treatment necessary for the liquid crystal alignment treatment, the film peeling and the cutting at the time of rubbing can be reduced, and the obtained liquid crystal alignment film has a high voltage holding ratio, and even for the liquid crystal cell When a DC voltage is applied, initial charge accumulation is less likely to occur. <Diamine of the formula [1]> The method for synthesizing the diamine represented by the formula [1] is not particularly limited, and for example, it may be a general formula obtained by combining φ into a dinitro compound represented by the following formula [S1]. The method synthesizes a method in which a nitro group is converted into an amine group. [Chemical 3]

[S1] 上述式Π)及式[S1]中之X係表示單鍵、碳數爲1〜3 之伸院基 ' -OCH2-、_CH2〇CO-、-NHCO-、-CONH-、或 -COOCH2-。 上述式[1)及式[si]中之γ係表示氧原子或硫原子。 Υ爲氧原子之五員環(以下也稱爲呋喃環)、或γ爲硫 原子之五員環(以下也稱爲噻吩環)之任意的氫原子可被碳 數1〜5之烷基取代。呋喃環或噻吩環之取代基之數較佳爲 〇〜2,更佳爲無取代。藉此可得到更佳的摩擦耐性。 上述式Π]及式[S1]中,呋喃環或噻吩環與χ結合的 位置無特別限定’較佳爲2位或3位的位置。 201030056 使用X爲-CH2OCO-、或-NHCO-之二胺所得之液晶配 向膜,作爲液晶面板時之電壓保持率升高。此外使用X 爲-CH2OCO-之二胺時,可得到液晶配向性優,電荷不易 蓄積的液晶面板,故較佳。 以式[1]表示之二胺中,苯環上之各取代基的位置無 特別限定。從作爲液晶配向膜時之液晶之配向性的觀點。 2個胺基之位置關係較佳爲間位或對位,此外從提高聚合 反應性或所得之聚醯胺酸或聚醯亞胺對有機溶劑之溶解性 的觀點,更佳爲間位。2個胺基之位置關係爲間位時,換 言之’ 1,3-二胺基苯結構時,X之位置較佳爲4或5的位 置’特別是從提高胺基之親核性的效果或容易合成的觀 點,更佳爲5的位置。 以式[1]表示之二胺中,ciS-二烯環(以下也稱爲呋喃 環或噻吩環)中之X結合的位置無特別限定,從原料取得 性、反應性等的觀點,此等之組合係配合目的適當選擇。 Y爲氧原子時(呋喃環時)之具體例如下述,但是不受 此限。 [化4][S1] The above formula Π) and the formula X in the formula [S1] represent a single bond, and the number of carbon atoms is 1 to 3, -OCH2-, _CH2〇CO-, -NHCO-, -CONH-, or - COOCH2-. The γ in the above formula [1) and formula [si] represents an oxygen atom or a sulfur atom. Any one of the five-membered ring of an oxygen atom (hereinafter also referred to as a furan ring) or a five-membered ring of γ as a sulfur atom (hereinafter also referred to as a thiophene ring) may be substituted with an alkyl group having 1 to 5 carbon atoms. . The number of substituents of the furan ring or the thiophene ring is preferably 〇 〜 2, more preferably unsubstituted. Thereby, better frictional resistance can be obtained. In the above formula 及] and the formula [S1], the position at which the furan ring or the thiophene ring is bonded to hydrazine is not particularly limited, and is preferably a position of 2 or 3 positions. 201030056 A liquid crystal alignment film obtained by using X as a -CH2OCO- or -NHCO-diamine increases the voltage holding ratio when used as a liquid crystal panel. Further, when a diamine wherein X is -CH2OCO- is used, a liquid crystal panel excellent in liquid crystal alignment property and in which electric charge is not easily accumulated can be obtained, which is preferable. In the diamine represented by the formula [1], the position of each substituent on the benzene ring is not particularly limited. From the viewpoint of the alignment of the liquid crystal when it is a liquid crystal alignment film. The positional relationship of the two amine groups is preferably a meta or para position, and more preferably from the viewpoint of improving the polymerization reactivity or the solubility of the obtained polyglycolic acid or polyimine in an organic solvent. When the positional relationship of the two amine groups is meta, in other words, the position of X is preferably 4 or 5 in the case of the '1,3-diaminobenzene structure', particularly from the effect of enhancing the nucleophilicity of the amine group or The point of easy synthesis is better than the position of 5. In the diamine represented by the formula [1], the position of the X bond in the ciS-diene ring (hereinafter also referred to as a furan ring or a thiophene ring) is not particularly limited, and from the viewpoints of raw material availability, reactivity, and the like, The combination is appropriately selected in accordance with the purpose. Specific examples of the case where Y is an oxygen atom (for the furan ring) are as follows, but are not limited thereto. [Chemical 4]

-10 201030056 (上述式中之X係表示單鍵、碳數爲1〜3之伸烷3 -OCH2-、-CH20C0-、-NHCO-、-CONH-、或-COOCH: 係表示碳原子數1~5之烷基’ n係表示〇〜3之整數) 上述式[Τ1]〜式[Τ6]中’ X較佳爲-CH2OCO-、或 -NHCO-,R較佳爲碳原子數1~3之烷基,η係較佳爲 1之整數。此外,上述式中,從聚醯胺酸或聚醯亞胺 劑溶解性、液晶配向性、摩擦耐性、蓄積電荷(以下 % 爲RDC)的觀點,較佳爲式[Τ2]或式[Τ5]的結構。 其中,較佳爲具有式[Τ2]或式[Τ5]的結構,X爲 -CH2OCO-、或-NHCO-,R爲碳數1〜3之烷基,η係〇 之整數者。使用連結基X爲-CH2OCO-或-NHCO-的 時,電壓保持率升高,特別是使用-CH2OCO-之二胺 液晶配向性特佳,故較理想。 Y爲硫原子時(噻吩環時)之具體例如下述,但是 此限制。 β [化 5]-10 201030056 (X in the above formula represents a single bond, an alkylene group having a carbon number of 1 to 3, -OCH2-, -CH20C0-, -NHCO-, -CONH-, or -COOCH: represents a carbon number of 1 The alkyl group of ~5 represents an integer of 〇~3. In the above formula [Τ1]~[[6], X is preferably -CH2OCO-, or -NHCO-, and R is preferably a carbon number of 1 to 3. The alkyl group and the η system are preferably an integer of 1. Further, in the above formula, from the viewpoints of solubility of polyglycine or polyimine, liquid crystal alignment, friction resistance, and accumulated charge (hereinafter referred to as RDC), it is preferably a formula [Τ2] or a formula [Τ5]. Structure. Among them, a structure of the formula [Τ2] or the formula [Τ5] is preferred, X is -CH2OCO- or -NHCO-, R is an alkyl group having 1 to 3 carbon atoms, and an integer of η is 〇. When the linking group X is -CH2OCO- or -NHCO-, the voltage holding ratio is increased, and in particular, the -CH2OCO-diamine liquid crystal is excellent in alignment, which is preferable. Specific examples of the case where Y is a sulfur atom (in the case of a thiophene ring) are as follows, but this limitation. β [化5]

-,R 〇或 之溶 也稱 或1 二胺 時, 不受-, R 〇 or soluble, also known as or 1 diamine, not

-,R-,R

(上述式中之X係表示單鍵、碳數爲1〜3之伸烷: -OCH2-、-CH2OCO-、-NHCO-、-CONH-、或-COOCH -11 - 201030056 係表示碳數1〜5之烷基,η係表示0~3之整數) 上述式[U1]~S[U6]中,X 較佳爲-CH2OCO-或-NHCO-,R較佳爲碳數1〜3之烷基,η較佳爲0或1之整數。 此外,上述式中,從聚醯胺酸或聚醯亞胺之溶劑溶解 性、液晶配向性、摩擦耐性、蓄積電荷(以下也稱爲RDC) 的觀點,較佳爲式[U2]或式[U5]的結構。 其中,較佳爲具有式[U2]或式[U5]的結構,X爲 -CH2OCO-或-NHCO-,R爲碳數1〜3之烷基,η爲0或1 @ 之整數者。使用連結基X爲-CH2OCO-或-NHCO-之二胺 時,電壓保持率升高,特別是使用-CH2OCO-之二胺時, 液晶配向性特佳,故較理想。 <二胺之合成> 本發明之特定二胺化合物係藉由合成式[S1]表示之二 硝基體,再使硝基還原,轉變成胺基而得。使二硝基化合 物還原的方法並無特別限制,通常係將鈀-碳、氧化鉑、 @ 拉尼鎳、鉑黑、鍺-氧化鋁、硫化鉑碳等作爲觸媒使用, 於乙酸乙酯、甲苯、四氫呋喃、二噁烷、醇系等溶劑中, 藉由氫氣、聯胺、氯化氫等進行的方法。下述式[S1]之X 係表示單鍵、碳數1〜3之伸烷基、-〇CH2-、-CH2OCO-、 -NHCO-、-CONH-、或-COOCH2-,Y係表示氧原子或硫原 子,五員環之任意的氫原子可被碳數1〜5之烷基取代。 -12- 201030056 [化6] 〇2N-Q [S1] ^N〇2 二硝基體之合成法係因結合基而各有不同。 X爲-CHsCOO-時,例如可藉由使二硝基苄醇與呋喃 羧酸或噻吩羧酸產生縮合反應得到二硝基體。縮合方法無 φ 特別限定’在鹼的存在下,使二硝基苄醇[S2]與殘酸氯 [S3]反應可得到二硝基體[S4]。其他,在脫水縮合劑存在 下,使醇與羧酸反應的方法等。(X in the above formula represents a single bond, an alkylene having a carbon number of 1 to 3: -OCH2-, -CH2OCO-, -NHCO-, -CONH-, or -COOCH-11 - 201030056 means a carbon number of 1~ 5 alkyl, η represents an integer of 0 to 3) In the above formula [U1]~S[U6], X is preferably -CH2OCO- or -NHCO-, and R is preferably an alkyl group having 1 to 3 carbon atoms. , η is preferably an integer of 0 or 1. Further, in the above formula, from the viewpoints of solvent solubility, liquid crystal alignment, friction resistance, and accumulated charge (hereinafter also referred to as RDC) of polyacrylic acid or polyimine, the formula [U2] or formula [preferably] The structure of U5]. Among them, a structure of the formula [U2] or the formula [U5] is preferred, X is -CH2OCO- or -NHCO-, R is an alkyl group having 1 to 3 carbon atoms, and η is an integer of 0 or 1 @. When a diamine having a linking group X of -CH2OCO- or -NHCO- is used, the voltage holding ratio is increased, and in particular, when a diamine of -CH2OCO- is used, liquid crystal alignment is particularly excellent, which is preferable. <Synthesis of Diamine> The specific diamine compound of the present invention is obtained by synthesizing a dinitro group represented by the formula [S1], reducing a nitro group, and converting it into an amine group. The method for reducing the dinitro compound is not particularly limited, and palladium-carbon, platinum oxide, @Rani nickel, platinum black, lanthanum-alumina, and platinum sulfide carbon are usually used as a catalyst, and ethyl acetate is used. A method of carrying out a solvent such as toluene, tetrahydrofuran, dioxane or an alcohol by hydrogen, hydrazine, hydrogen chloride or the like. X of the following formula [S1] represents a single bond, an alkylene group having 1 to 3 carbon atoms, -〇CH2-, -CH2OCO-, -NHCO-, -CONH-, or -COOCH2-, and Y represents an oxygen atom. Or a sulfur atom, any hydrogen atom of the five-membered ring may be substituted with an alkyl group having 1 to 5 carbon atoms. -12- 201030056 化2N-Q [S1] ^N〇2 The synthesis method of the dinitro group differs depending on the bonding group. When X is -CHsCOO-, for example, a dinitrobenzene can be obtained by subjecting dinitrobenzyl alcohol to a condensation reaction with furancarboxylic acid or thiophenecarboxylic acid. The condensation method is not limited to φ. The dinitrobenzene [S4] can be obtained by reacting dinitrobenzyl alcohol [S2] with residual acid chlorine [S3] in the presence of a base. Further, a method of reacting an alcohol with a carboxylic acid in the presence of a dehydrating condensing agent.

[化7][Chemistry 7]

Base SolventBase Solvent

X爲-NHCΟ-時,例如藉由使二硝基苯胺與呋喃羧酸 或噻吩羧酸產生縮合反應可得到二硝基體。縮合方法無特 別限定,在鹼的存在下,使二硝基苯胺[S 5]與羧酸氯[S 6] 反應,可得到二硝基體[S 7]。其他,例如有在脫水縮合劑 存在下,使胺與羧酸產生反應的方法等。 -13- 201030056 [化8] NH, id + P „ HN-^ ^jfCOCI Base Solvent 〇2ΝΛΛΝ〇2 [S5] [S6】 [S7] X爲- COOCH2 -例如藉由使二硝基苯甲酸與呋喃甲醇 或噻吩甲醇產生縮合反應可得到。縮合方法無特別限定, 在鹼的存在下,使二硝基苯甲酸氯[S8]與醇[S9]反應可得 到二硝基體[S 1 0]。其他,例如有在脫水縮合劑存在下, 使醇與羧酸反應的方法等。 [化9] o2n COCIJ0L ^^Ν〇2When X is -NHCΟ-, the dinitro group can be obtained, for example, by subjecting dinitroaniline to condensation reaction with furancarboxylic acid or thiophenecarboxylic acid. The condensation method is not particularly limited, and a dinitrobenzene [S 7] can be obtained by reacting dinitroaniline [S 5] with a carboxylic acid chloride [S 6] in the presence of a base. Other examples include a method of reacting an amine with a carboxylic acid in the presence of a dehydrating condensing agent, and the like. -13- 201030056 [Chem. 8] NH, id + P „ HN-^ ^jfCOCI Base Solvent 〇2ΝΛΛΝ〇2 [S5] [S6] [S7] X is - COOCH2 - for example by dinitrobenzoic acid with furan A condensation reaction can be obtained by methanol or thiophene methanol. The condensation method is not particularly limited, and a dinitroso group [S 1 0] can be obtained by reacting dinitrobenzoic acid chloride [S8] with an alcohol [S9] in the presence of a base. For example, there is a method of reacting an alcohol with a carboxylic acid in the presence of a dehydrating condensing agent, etc. [Chemical 9] o2n COCIJ0L ^^Ν〇2

Base SolventBase Solvent

02N02N

[S8] [S9] [S10][S8] [S9] [S10]

使用烷基加成於呋喃環、或噻吩環的試藥或或預先烷 基加成,可得到呋喃環(或噻吩環)上附有側鏈者。 <二胺成分> 上述式[1]表示之二胺係藉由與四羧酸二酐反應,可 得到聚醯胺酸,使此聚醯胺酸進行醯亞胺化可得到聚醯亞 胺。本發明中,合成聚醯胺酸時使用的二胺成分可僅爲式 -14 - 201030056 [1]表示之二胺,或選自其他二胺之1種或2種以上之組 合。 含有作爲二胺成分之式[1]表示之二胺,可提高所得 之聚醯胺酸及此聚醯胺酸經醯亞胺化的聚醯亞胺對有機溶 記的溶解性。此外,由含有此聚醯胺酸或聚醯亞胺之液晶 配向處理劑所得的液晶配向膜係摩擦耐性優異,電壓保持 率高,且對於液晶胞施加直流電壓,變得不易產生初期之 φ 電荷蓄積。爲了得到這種特性時,式[1]表示之二胺較佳 爲聚醯胺酸之合成使用之二胺成分整體的1 0〜1 OOmol%, 更佳爲 20~100mol%,特佳爲 ΜΜΟΟιηοΙ%。 上述之二胺成分中,與式[丨]表示之二胺組合使用的 二胺無特別限定。這種二胺之具體例如下述。 脂環二胺例如有丨,心二胺基環己烷、丨,3_二胺基環己 烷、4,4’-二胺基二環己基甲烷、4,4,-二胺基-3,3,-二甲基 一環己基胺、異佛爾酮二胺等。 ® 方香族一胺例如有0 -苯二胺、m -苯二胺、p -苯二胺、 2,4-二胺基甲苯、2,5-二胺基甲苯、3,5_二胺基甲苯、3,5_ 二胺基-N,N-二稀丙基苯胺、2,4_二胺基_N,N_二烯丙基苯 胺、1,4-二胺基-2-甲氧基苯、2,5•二胺基-p_二甲苯、丨,3_ 二胺基-4-氯苯、3,5-二胺基苯甲酸、二胺基_2,5_二氯 苯、4,4’-二胺基-l,2_二苯基乙烷、4,4,·二胺基·2,2’_二甲 基聯节、4,4’-二胺基二苯基甲烷、3,3,_二胺基二苯基甲 院、3,4’-一胺基二苯基甲烷、4,4’_二胺基_3,3’二甲基二 苯基甲烷、2,2’- 基芪、4,4’-二胺基芪、4,4’-二胺基 -15- 201030056 二苯醚、3,4’-二胺基二苯醚、4,4’-二胺基二苯基硫醚、 4,4’ -二胺基二苯基颯、3,3’ -二胺基二苯基颯、4,4’ -二胺 基二苯甲酮、1,3-雙(3-胺基苯氧基)苯、1,3-雙(4-胺基苯 氧基)苯、1,4-雙(4-胺基苯氧基)苯、3,5-雙(4-胺基苯氧基) 苯甲酸、4,4’-雙(4-胺基苯氧基)聯苄、2,2-雙[(4-胺基苯 氧基)甲基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙 烷、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、雙[4-(3-胺基苯 氧基)苯基]碾、雙[4-(4-胺基苯氧基)苯基]颯、1,1-雙(4-胺 基苯基)環己烷、α,α’-雙(4_胺基苯基)-1,4-二異丙基苯、 9,9-雙(4-胺基苯基)芴、2,2-雙(3-胺基苯基)六氟丙烷、 2,2-雙(4-胺基苯基)六氟丙烷、4,4’-二胺基二苯基胺、 2,4-二胺基二苯基胺、1,8-二胺基萘、1,5-二胺基萘、1,5-二胺基蒽醌、1,3-二胺基芘、1,6-二胺基芘、1,8-二胺基 芘、2,7-二胺基芴、1,3-雙(4-胺基苯基)四甲基二矽氧烷、 聯苯胺、2,2’-二甲基聯苯胺、1,2-雙(4-胺基苯基)乙烷、 1,3-雙(4_胺基苯基)丙烷、1,4-雙(4-胺基苯基)丁烷、1,5-雙(4-胺基苯基)戊烷、1,6-雙(4-胺基苯基)己烷、1,7-雙(4-胺基苯基)庚烷、1,8-雙(4_胺基苯基)辛烷、1,9-雙(4-胺基 苯基)壬烷、1,1〇_雙(4-胺基苯基)癸烷、1,3-雙(4-胺基苯 氧基)丙烷、1,4_雙(4_胺基苯氧基)丁烷、1,5-雙(4_胺基苯 氧基)戊烷、1,6-雙(4-胺基苯氧基)己烷、1,7-雙(4-胺基苯 氧基)庚烷、1,8-雙(4-胺基苯氧基)辛烷、1,9-雙(4-胺基苯 氧基)壬烷、1,10-雙(4-胺基苯氧基)癸烷、二(4_胺基苯基) 丙烷-1,3-二酸酯、二(4-胺基苯基)丁烷-1,4-二酸酯、二 -16- 201030056 (4-胺基苯基)戊烷-1,5-二酸酯、二(4-胺基苯基)己烷_i,6-二酸酯、二(4-胺基苯基)庚烷-1,7-二酸酯、二(4-胺基苯基) 辛烷-1,8-二酸酯、二(4-胺基苯基)壬烷-1,9-二酸酯、二 (4-胺基苯基)癸烷-1,10-二酸酯、ι,3-雙〔4-(4-胺基苯氧 基)苯氧基〕丙烷、1,4-雙〔4-(4-胺基苯氧基)苯氧基〕丁 烷、1,5-雙〔4-(4-胺基苯氧基)苯氧基〕戊烷、1,6-雙〔4-(4-胺基苯氧基)苯氧基〕己烷、1,7-雙〔4-(4-胺基苯氧基) φ 苯氧基〕庚烷、1,8-雙〔4-(4-胺基苯氧基)苯氧基〕辛 烷、1,9-雙〔4-(4-胺基苯氧基)苯氧基〕壬烷、1,10-雙 〔4-(4-胺基苯氧基)苯氧基〕癸烷等。 雜環二胺例如有2,6-二胺基吡啶、2,4-二胺基吡啶、 2,4-二胺基-1,3,5-三嗪、2,7-二胺基二苯並呋喃、3,6-二胺 基咔唑、2,4-二胺基-6-異丙基-1,3,5-三嗪、2,5-雙(4-胺基 苯基)-1,3,4-噁二唑等。 脂肪族二胺例如有1,2-二胺基乙烷、1,3-二胺基丙 • 烷、I,4·二胺基丁烷、I,5-二胺基戊烷、1,6-二胺基己 烷、1,7-二胺基庚烷、1,8_二胺基辛烷、1,9-二胺基壬 烷、1,10-二胺基癸烷、1,3-二胺基-2,2-二甲基丙烷、1,6_ 二胺基-2,5-二甲基己烷、l,7-二胺基-2,5-二甲基庚烷、 I,7·二胺基_4,4·二甲基庚烷、1,7-二胺基_3·甲基庚烷、 1,9-二胺基-5-甲基庚烷、ι,ΐ2-二胺基十二烷、丨,18·二胺 基十八烷、1,2-雙(3-胺基丙氧基)乙烷等。 芳香族-脂肪族二胺之例如有式Π 1 ]表示之二胺。 -17- 201030056 [化 10] h^N—Ar—^—NH—R2 [11] 上述式中之Ar係表示伸苯基伸萘基,Ri係碳數i〜5 之伸院基,R~2係氫原子或甲基。 式[11]表示之二胺之具體例有3-胺基苄胺、4-胺基节 胺、3-胺基-N-甲基苄胺、4-胺基-N-甲基苄胺、3_胺基苯 乙胺、4-胺基苯乙胺、3-胺基-N-甲基苯乙胺、4-胺基-N_ 甲基苯乙胺、3-(3-胺基丙基)苯胺、4-(3-胺基丙基)苯胺、 3-(3-甲基胺基丙基)苯胺、4-(3-甲基胺基丙基)苯胺、3_ (4-胺基丁基)苯胺、4-(4-胺基丁基)苯胺、3-(4-甲基胺基 丁基)苯胺、4-(4-甲基胺基丁基)苯胺、3-(5·胺基戊基)苯 胺、4-(5-胺基戊基)苯胺、3-(5-甲基胺基戊基)苯胺、4_ (5-甲基胺基戊基)苯胺、2-(6-胺基萘基)甲胺、3-(6-胺基 萘基)甲胺、2-(6-胺基萘基)乙胺、3-(6-胺基萘基)乙胺 等,但是不限於此等。 式[11]表示之二胺與式[1]表示之二胺組合倂用時,可 進一步提高所得之聚醯胺酸或聚醯亞胺(以下此等稱爲聚 合物)對有機溶劑之溶解性,作爲液晶配向膜使用時,液 晶配向性優異,故較佳。與後述之擴大液晶之預傾角之二 胺(以下也稱爲傾斜二胺)倂用時,具有可進一步擴大液晶 之預傾角的效果。因此爲了得到相同大小之預傾角時,即 使減少傾斜二胺的使用量,也可得到較大的預傾角。此 外’也可期待改善液晶配向處理劑之印刷性。 -18 - 201030056 式[11]表示之二胺之較佳含量係二胺成分 10〜80mol%,更佳爲 20〜70mol%。 可擴大液晶之預傾角之二胺(傾斜二胺),例如 長鏈院基、全氟烷基、芳香族環狀基、脂肪族環狀 些之組合的取代基、類固醇骨架基等的二胺。此等 可與式[1]表示之二胺組合倂用。 以下列舉具有此等取代基之二胺的具體例,但 φ 明不限於此等。以下所例示之式[13]〜式[38]中, 示5~20的整數,k係表示1〜20的整數。A side chain to which a furan ring (or a thiophene ring) is attached may be obtained by using a reagent in which an alkyl group is added to a furan ring or a thiophene ring or a pre-alkyl group addition. <Diamine component> The diamine represented by the above formula [1] can be obtained by reacting with a tetracarboxylic dianhydride to obtain a poly-proline, and the polyamine can be imidized to obtain a polyazide. amine. In the present invention, the diamine component used in the synthesis of the polyamic acid may be only a diamine represented by the formula -14 - 201030056 [1] or a combination of one or more selected from the other diamines. The diamine represented by the formula [1] as a diamine component can improve the solubility of the obtained polylysine and the polyamidimide of the polyamidamine in organic solubility. Further, the liquid crystal alignment film obtained from the liquid crystal alignment treatment agent containing the polyamic acid or the polyimine is excellent in friction resistance, high in voltage holding ratio, and a direct current voltage is applied to the liquid crystal cell, and the initial φ charge is less likely to occur. Accumulate. In order to obtain such a characteristic, the diamine represented by the formula [1] is preferably from 10 to 100 mol%, more preferably from 20 to 100 mol%, more preferably from 20 to 100 mol%, particularly preferably ΜΜΟΟιηοΙ, of the diamine component used for the synthesis of the polyamic acid. %. Among the above diamine components, the diamine used in combination with the diamine represented by the formula [丨] is not particularly limited. Specific examples of such a diamine are as follows. The alicyclic diamine is, for example, anthracene, heart diaminocyclohexane, hydrazine, 3-diaminocyclohexane, 4,4'-diaminodicyclohexylmethane, 4,4,-diamino-3 , 3,-dimethyl monocyclohexylamine, isophorone diamine, and the like. ® scented aromatic amines such as 0-phenylenediamine, m-phenylenediamine, p-phenylenediamine, 2,4-diaminotoluene, 2,5-diaminotoluene, 3,5-diamine Toluene, 3,5-diamino-N,N-dipropylaniline, 2,4-diamino-N,N-diallylaniline, 1,4-diamino-2-methoxy Benzobenzene, 2,5•diamino-p-xylene, anthracene, 3-diamino-4-chlorobenzene, 3,5-diaminobenzoic acid, diamino-2,5-dichlorobenzene, 4,4'-diamino-1,2-diphenylethane, 4,4,diamino-2,2'-dimethyl linked, 4,4'-diaminodiphenyl Methane, 3,3,-diaminodiphenylmethyl, 3,4'-monoaminodiphenylmethane, 4,4'-diamino-3,3'dimethyldiphenylmethane, 2,2'-ylindole, 4,4'-diaminopurine, 4,4'-diamino-15-201030056 diphenyl ether, 3,4'-diaminodiphenyl ether, 4,4' -diaminodiphenyl sulfide, 4,4'-diaminodiphenylanthracene, 3,3'-diaminodiphenylanthracene, 4,4'-diaminobenzophenone, 1 , 3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenoxy)benzene, 3,5 -bis(4-aminophenoxy)benzene Formic acid, 4,4'-bis(4-aminophenoxy)bibenzyl, 2,2-bis[(4-aminophenoxy)methyl]propane, 2,2-bis[4-(4 -aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, bis[4-(3-aminophenoxy)benzene Grinding, bis[4-(4-aminophenoxy)phenyl]indole, 1,1-bis(4-aminophenyl)cyclohexane, α,α'-bis(4-amino Phenyl)-1,4-diisopropylbenzene, 9,9-bis(4-aminophenyl)anthracene, 2,2-bis(3-aminophenyl)hexafluoropropane, 2,2- Bis(4-aminophenyl)hexafluoropropane, 4,4'-diaminodiphenylamine, 2,4-diaminodiphenylamine, 1,8-diaminonaphthalene, 1,5 -diaminonaphthalene, 1,5-diaminoguanidine, 1,3-diaminoguanidine, 1,6-diaminoguanidine, 1,8-diaminoguanidine, 2,7-diamine芴, 1,3-bis(4-aminophenyl)tetramethyldioxane, benzidine, 2,2'-dimethylbenzidine, 1,2-bis(4-aminophenyl) Ethane, 1,3-bis(4-aminophenyl)propane, 1,4-bis(4-aminophenyl)butane, 1,5-bis(4-aminophenyl)pentane, 1,6-bis(4-aminophenyl)hexane, 1,7-bis(4-aminophenyl) Heptane, 1,8-bis(4-aminophenyl)octane, 1,9-bis(4-aminophenyl)decane, 1,1〇-bis(4-aminophenyl)anthracene Alkane, 1,3-bis(4-aminophenoxy)propane, 1,4-bis(4-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane Alkane, 1,6-bis(4-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy) Octane, 1,9-bis(4-aminophenoxy)decane, 1,10-bis(4-aminophenoxy)decane, bis(4-aminophenyl)propane-1, 3-Diester, bis(4-aminophenyl)butane-1,4-dicarboxylate, di-16-201030056 (4-aminophenyl)pentane-1,5-dicarboxylate, Bis(4-aminophenyl)hexane_i,6-diester, bis(4-aminophenyl)heptane-1,7-diester, bis(4-aminophenyl) octane Alkenyl-1,8-diester, bis(4-aminophenyl)decane-1,9-diester, bis(4-aminophenyl)decane-1,10-diester, ι,3-bis[4-(4-aminophenoxy)phenoxy]propane, 1,4-bis[4-(4-aminophenoxy)phenoxy]butane, 1,5 - bis[4-(4-aminophenoxy)phenoxy] Alkane, 1,6-bis[4-(4-aminophenoxy)phenoxy]hexane, 1,7-bis[4-(4-aminophenoxy) φ phenoxy]heptane 1,8-bis[4-(4-aminophenoxy)phenoxy]octane, 1,9-bis[4-(4-aminophenoxy)phenoxy]decane, 1 , 10-bis[4-(4-aminophenoxy)phenoxy]decane, and the like. Heterocyclic diamines are, for example, 2,6-diaminopyridine, 2,4-diaminopyridine, 2,4-diamino-1,3,5-triazine, 2,7-diaminodiphenyl And furan, 3,6-diaminocarbazole, 2,4-diamino-6-isopropyl-1,3,5-triazine, 2,5-bis(4-aminophenyl)- 1,3,4-oxadiazole and the like. The aliphatic diamines are, for example, 1,2-diaminoethane, 1,3-diaminopropane, I,4,diaminobutane, I,5-diaminopentane, 1,6 -diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane, 1,10-diaminodecane, 1,3 -diamino-2,2-dimethylpropane, 1,6-diamino-2,5-dimethylhexane, 1,7-diamino-2,5-dimethylheptane, I ,7·diamino-4,4·dimethylheptane, 1,7-diamino-3·methylheptane, 1,9-diamino-5-methylheptane, ι,ΐ2 -diaminododecane, anthracene, 18.diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, and the like. The aromatic-aliphatic diamine has, for example, a diamine represented by the formula Π 1 ]. -17- 201030056 h^N—Ar—^—NH—R2 [11] The Ar in the above formula represents a phenylphenylnaphthyl group, and the Ri is a carbon number i~5. Is a hydrogen atom or a methyl group. Specific examples of the diamine represented by the formula [11] include 3-aminobenzylamine, 4-amino benzylamine, 3-amino-N-methylbenzylamine, 4-amino-N-methylbenzylamine, 3-aminophenethylamine, 4-aminophenethylamine, 3-amino-N-methylphenethylamine, 4-amino-N-methylphenylethylamine, 3-(3-aminopropyl) Aniline, 4-(3-aminopropyl)aniline, 3-(3-methylaminopropyl)aniline, 4-(3-methylaminopropyl)aniline, 3-(4-aminobutyl) Aniline, 4-(4-aminobutyl)aniline, 3-(4-methylaminobutyl)aniline, 4-(4-methylaminobutyl)aniline, 3-(5.amine Benido)aniline, 4-(5-aminopentyl)aniline, 3-(5-methylaminopentyl)aniline, 4-(5-methylaminopentyl)aniline, 2-(6- Aminonaphthyl)methylamine, 3-(6-aminonaphthyl)methylamine, 2-(6-aminonaphthyl)ethylamine, 3-(6-aminonaphthyl)ethylamine, etc., but not Limited to this. When the diamine represented by the formula [11] is used in combination with the diamine represented by the formula [1], the obtained polylysine or polyimine (hereinafter referred to as a polymer) can be further dissolved in an organic solvent. When it is used as a liquid crystal alignment film, it is preferable because it is excellent in liquid crystal alignment. When diamine (hereinafter also referred to as a tilted diamine) which expands the pretilt angle of the liquid crystal described later is used, the effect of further increasing the pretilt angle of the liquid crystal is obtained. Therefore, in order to obtain a pretilt angle of the same size, a large pretilt angle can be obtained even if the amount of the tilted diamine used is reduced. Further, it is expected to improve the printability of the liquid crystal alignment agent. -18 - 201030056 The preferred content of the diamine represented by the formula [11] is 10 to 80 mol%, more preferably 20 to 70 mol%, based on the diamine component. A diamine (slanted diamine) which can expand a pretilt angle of a liquid crystal, for example, a long chain compound, a perfluoroalkyl group, an aromatic cyclic group, a substituent of a combination of an aliphatic ring group, a diamine such as a steroid skeleton group, or the like . These can be used in combination with the diamine represented by the formula [1]. Specific examples of the diamine having such a substituent are listed below, but φ is not limited thereto. In the formula [13] to the formula [38] exemplified below, an integer of 5 to 20 is shown, and k is an integer of 1 to 20.

Mk11] 髮體之 有具有 基及适 之二胺 是本發 j係表 h2 nh2 4 0(CH2)j〇H3 [12] H 少l_ nh2 nh2 h2n_Mk11] has a basal and suitable diamine. This is a j-series h2 nh2 4 0(CH2)j〇H3 [12] H less l_ nh2 nh2 h2n_

_ 一 __. ^ """^~^-〇(CH2^H3 兮 [13] <CH2>kCH3 [14]_ a __. ^ """^~^-〇(CH2^H3 兮 [13] <CH2>kCH3 [14]

(CH2)lPH3 [15] -19- 201030056 [化 12] nh2h2-^^N V-o ^-〇(CH2)kCH3 Ο H2 H2NY^A〇,C^^O(CH2)kCH3 [17] NH2 0(CH2)kCH3(CH2)lPH3 [15] -19- 201030056 [Chemical 12] nh2h2-^^N Vo ^-〇(CH2)kCH3 Ο H2 H2NY^A〇,C^^O(CH2)kCH3 [17] NH2 0(CH2 )kCH3

[1S][1S]

0(CH2)kCH3 [化 13] nh2 (CH2)kCH3 [19] H2N—0(CH2)kCH3 [Chemical 13] nh2 (CH2)kCH3 [19] H2N—

HjM— ^〇-〇~〇-(cH2)kCH3 RO] O~0~0~ (CH2)kCH3 [21]HjM— ^〇-〇~〇-(cH2)kCH3 RO] O~0~0~ (CH2)kCH3 [21]

-20- 201030056 [化 14]-20- 201030056 [Chem. 14]

(CH2)kCHb [22](CH2)kCHb [22]

[2句 [化 15] h2n νη2 V (叫叫 Η2Ν^_, [27] />~ΝΗ.[2 sentences [化15] h2n νη2 V (called Η2Ν^_, [27] />~ΝΗ.

H2NH2N

Ο 0:9 0(CH2)kCH3 [28] η2ν·Ο 0:9 0(CH2)kCH3 [28] η2ν·

ΝΗ 2 [30] 乂ΟτΟγ OCF3 νη2Η2Ν-^^-°-^^—(^)— (CH2)kCH3 [31] -21 - 201030056 [化 16]ΝΗ 2 [30] 乂ΟτΟγ OCF3 νη2Η2Ν-^^-°-^^—(^)—(CH2)kCH3 [31] -21 - 201030056 [Chem. 16]

[33][33]

H2NH2N

[35] [34】 (CHa^OHj[35] [34] (CHa^OHj

[化Π][Π化]

± ''批之二胺中,式[1 2 ]之二胺係液晶配向性優異’故 較佳。式[I9]〜[26]之二胺係預傾角之展現能非常高’故適 用於 〇CB(Optically Compensated Bend)液晶用配向膜(以 -22- 201030056 下爲OCB用配向膜)、垂直配向模式液晶用配向膜(以下 爲VA用配向膜)。 例如TN液晶用配向膜(預傾角爲3~5°)時,式[12]之 二胺之含量較佳爲二胺成分整體之10~30mol%,而OCB 用配向膜、或 VA用配向膜(預傾角爲10〜90°)時,式 [19]~[26]之二胺之含量較佳爲二胺成分整體之5〜40mol% ,但是不限於此。 φ 考慮本發明之液晶配向處理劑所使用之聚醯胺酸或聚 醯亞胺之溶解性、液晶之配向性、傾斜角、電壓保持率、 蓄積電荷等之各特性的平衡時,使用例如式[1]、式[11]、 及式[12]表示之二胺成分進行聚合時,各自之二胺成分之 較佳比率係以莫耳比表示,較佳爲 1〇〜50%(式 [1])/20~80%(式[11])/10〜30%(式[12]),更佳爲 20〜40%/ 3 0~50%/10~3 0〇/〇,但是不限於此。 〇 〈四羧酸二酐成分&gt; 本發明之液晶配向處理劑所需要的聚醯胺酸或聚醯亞 胺中,與上述之二胺成分反應的四羧酸二酐成分無特別限 定。換言之’可爲1種類之四羧酸二酐或倂用2種類以上 之四羧酸二酐。 本發明之液晶配向處理劑’從進一步提高液晶胞之電 壓保持率的觀點等,使與前述二胺成分反應的四殘酸二酐 較佳爲使用具有脂環結構或脂肪族結構的四殘酸二酐。 具有脂環結構或脂肪族結構之四殘酸二酐例如有 -23- 201030056 1,2,3,4-環丁院四殘酸二肝、1,2-二甲基-1,2,3,4-環丁院四 羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、 1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊 烷四羧酸二酐、2,3,4,5-四氫呋喃四羧酸二酐、1,2,4,5-環 己烷四羧酸二酐、3,4-二羧基-1-環己基琥珀酸二酐、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸二酐、〔4-(2,5-二氧代四 氫呋喃-3-基)-1,2,3,4-四氫萘-1,2-二羧酸二酐〕、1,2,3,4-丁烷四羧酸二酐、雙環〔3,3,0〕辛烷-2,4,6,8-四羧酸二 酐、3,3’,4,4’-二環己基四羧酸二酐、2,3,5-三羧基環戊基 乙酸二酐、順式-3,7 -二丁基環辛-1,5 -二烯-1,2,5,6-羧酸二 酐、三環[4.2.1.〇2,5]壬烷-3,4,7,8-四羧酸-3,4:7,8-二酐、 六環[6_6.0.12,7.03,6.19,14.010,13]十六烷-4,5,11,12-四羧 酸-4,5:11,12-二酐等。其中特別是使用1,2,3,4-環丁烷四 羧酸二酐時’可得到液晶配向性優異的配向膜,故較佳。 倂用芳香族四羧酸二酐時,可提高液晶配向性,且可 迅速排除液晶胞之蓄積電荷。芳香族四羧酸二酐例如有均 苯四酸二酐、3,3’,4,4,-聯苯四羧酸二酐、2,2’,3,3’-聯苯 四羧酸二酐、2,3,3’,4-聯苯四羧酸二酐、3,3’,4,4’-二苯甲 酮四羧酸二酐、2,3,3’,4-二苯甲酮四羧酸二酐、雙(3,4-二 羧基苯基)醚二酐、雙(3,4·二羧基苯基)碾二酐、1,2,5,6-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐等。其中較佳爲均 苯四酸二酐。 考慮所得之聚醯胺酸或聚醯亞胺之溶解性、液晶之配 向性、電壓保持率、蓄積電荷等之各特性之平衡時,具有 -24- 201030056 脂環結構或脂肪族結構之四羧酸二酐與芳香族四羧酸二酐 之使用比率係以前者/後者之莫耳比表示,較佳爲 90/10~50/50,更佳爲 80/20〜60/40 ° &lt;聚合反應&gt; 本發明中,四羧酸二酐成分與二胺成分之聚合反應方 法無特別限定。一般而言,在有機溶劑中以混合進行聚合 φ 反應,可得到聚醯胺酸,此聚醯胺酸藉由脫水閉環,可成 爲聚醯亞胺。 使四羧酸二酐成分與二胺成分於有機溶劑中混合的方 法,例如有使二胺成分分散或溶解於有機溶劑之溶液進行 攪拌,將四羧酸二酐成分直接或經分散或溶解於有機溶劑 來添加的方法,相反地,使二胺成分添加於將四羧酸二酐 分散或溶解於有機溶劑之溶液中的方法,或交互添加四羧 酸二酐與二胺成分的方法等。此外,四羧酸二酐或二胺成 φ 分爲複數種化合物所構成時,可將此等複數種成分事先混 合之狀態,進行聚合反應,或可各別依序進行聚合反應。 四羧酸二酐成分與二胺成分在有機溶劑中進行聚合反 應時之溫度通常爲 〇〜150°C,較佳爲 5〜100°C,更佳爲 10~80°C。溫度較高時,聚合反應快速結束,但是太高 時,有時無法得到高分子量之聚合物。 可以任意濃度進行聚合反應,但是四羧酸二酐成分與 二胺成分之合計濃度太低時,很難得到高分子量的聚合 物,濃度太高時,反應液之黏性太高,均句攪拌困難,因 -25- 201030056 此合計濃度較佳爲1~50質量%,更佳爲5〜30質量%。聚 合反應初期係以高濃度進行,其後可追加有機溶劑。 上述聚合反應時所用之有機溶劑係只要是可溶解生成 之聚醯胺酸者時,無特別限定。其具體例爲N,N’-二甲基 甲醯胺、Ν,Ν’-二甲基乙醯胺、N-甲基-2-吡咯烷酮、N-乙 基-2-吡咯烷酮、Ν -甲基己內醯胺、二甲基亞颯、四甲基 尿素、吡啶、二甲基楓、六甲基亞碾、Τ -丁內酯、1,3-二 甲基咪唑啉酮等。此等可單獨使用或混合使用。即使爲不 _ 溶解聚醯胺酸之溶劑,在不會使生成之聚醯胺酸析出的範 圍內,也可與上述溶劑混合使用。此外,有機溶劑中之水 分係阻礙聚合反應,也成爲生成之聚醯胺酸產生水解的原 因,因此有機溶劑盡可能使用經脫水乾燥者。 聚醯胺酸之聚合反應所用的四羧酸二酐成分與二胺成 分之比率以莫耳比表示,較佳爲1:0.8~1:1.2,此莫耳比 越接近1:1,所得之聚醯胺酸之分子量越大。控制此聚醯 胺酸的分子量可調整醯亞胺化後,所得之聚醯亞胺的分子 〇 量。 本發明之聚醯胺酸或聚醯亞胺的分子量並沒特別的限 定,含有於液晶配向處理劑時,從所得之塗膜的強度與作 爲液晶配向處理劑之操作容易度的觀點,以重量平均分子 量表示,較佳爲2,000~200,〇00,更佳爲5,000〜50,000。 &lt;聚醯亞胺之合成&gt; 本發明之液晶配向處理劑所使用之聚醯亞胺係將上述 -26- 201030056 聚醯胺酸進行醯亞胺化後的聚醯亞胺。聚醯胺酸之醯亞胺 化係在有機溶劑中,鹼性觸媒與酸酐之存在下,藉由攪拌 1〜100小時來進行。 鹼性觸媒例如有吡啶、三乙胺、三甲胺、三丁胺、三 辛胺等。其中吡啶係具有進行反應所需之適度的鹼性,因 此較佳。 又,酸酐例如有乙酸酐、偏苯三酸酐、苯均四甲酸酐 Φ 等。其中乙酸酐係在醯亞胺化結束後,所得之聚醯亞胺之 純化變得容易,故較佳。 有機溶劑可使用前述聚醯胺酸聚合反應所用的溶劑。 聚醯亞胺之醯亞胺化率可藉由調節觸媒量、反應溫 度、反應時間等來控制。此時之鹼性觸媒的量較佳爲醯胺 酸基之0.2~10倍莫耳,更佳爲0.5〜5倍莫耳。酸酐之量 較佳爲醯胺酸基之1〜3 0倍莫耳,更佳爲1~10倍莫耳。反 應溫度較佳爲-20°C~250°C,更佳爲0°C〜180°C。 φ 本發明之液晶配向處理劑所使用之聚醯亞胺之醯亞胺 化率無特別限定,但是從可得到更高電壓保持率之液晶配 向膜的理由,醯亞胺化率較佳爲40%以上,更佳爲60%以 上,特佳爲8 0 %以上。 如此所得之聚醯亞胺之溶液中,因殘留著添加後的觸 媒等,因此用於液晶配向處理劑時,將聚醯亞胺回收、洗 淨後再使用較佳。 聚醯亞胺之回收係將醯亞胺化後之溶液投入攪拌之弱 溶劑之攪拌下,使聚醯亞胺析出後可過濾。此時之弱溶劑 -27- 201030056 例如有甲醇、丙酮、己烷、丁基溶纖素、庚烷、甲基乙基 酮、甲基異丁基酮、乙醇、甲苯、苯等。回收後之聚醯亞 胺之洗淨也可使用此弱溶劑。如此回收、洗淨後的聚醯亞 胺可在常壓或減壓下,於常溫或加熱乾燥成爲粉末。 此種操作也可對於前述之聚醯胺酸進行。例如欲在液 晶配向處理劑中不含有聚醯胺酸之聚合所用之溶劑時或欲 去除反應溶液中未反應之單體或雜質時,進行上述之沈澱 回收及純化即可。 &lt;液晶配向處理劑&gt; 本發明之液晶配向處理劑係含有選自如上述所得之聚 醯胺酸及聚醯亞胺中之至少一種聚合物的塗佈液。 其製造例有將前述聚醯胺酸或聚醯亞胺之反應溶液直 接、或經稀釋後者,或由反應液經沈澱回收者再溶解於有 機溶劑中。稀釋或再溶解之步驟中,可調整用於控制基板 之塗佈性的溶劑組成或追加用於改善塗膜特性的添加物 @ 等。也可與上述不同結構之聚醯亞胺溶液或聚醯胺酸溶液 混合或添加其他樹脂成分。 上述稀釋或再溶解步驟所使用之有機溶劑,只要是溶 解含有的聚合物者,即無特別限定。其具體例有N,N_二 甲基甲醯胺、N,N-二甲基乙醯胺、N-甲基-2-吡咯烷酮、 N-甲基己內醯胺、2-吡咯烷酮、N-乙基-2-吡咯烷酮、N-乙烯基吡咯烷酮、二甲基亞砸、四甲基尿素、二甲基颯、 六甲基亞碾、r-丁內酯、1,3-二甲基-咪唑啉酮等。其中 -28- 201030056 較佳爲N -甲基-2-卩仕略院酮、N -乙基_2_卩比略垸酮、ι,3 -二 甲基-咪唑啉酮、γ-丁內酯。這些可1種或混合2種以上 使用。 用於控制液晶配向處理劑對基板之塗佈性所添加的溶 劑’例如有乙基溶纖素、丁基溶纖素、乙基卡必醇、丁基 卡必醇、乙基卡必醇乙酸酯、乙二醇、1-甲氧基-2 -丙 醇、卜乙氧基-2-丙醇、1-丁氧基-2-丙醇、1-苯氧基-2-丙 _ 醇、二乙二醇二乙醚、丙二醇單乙酸酯、丙二醇二乙酸 酯、二丙二醇單甲醚、丙二醇-1-單甲醚-2-乙酸酯、丙二 醇-1-單乙醚_2_乙酸酯、二丙二醇、2-(2-乙氧基丙氧基)丙 醇、乳酸甲酯、乳酸乙酯、乳酸正丙酯、乳酸正丁酯、乳 酸異戊酯等。這些溶劑也含有單獨無法溶解聚醯胺酸或聚 醯亞胺之溶劑,但是在聚合物不會析出的範圍內,可與本 發明之液晶配向處理劑混合。特別是藉由適度混合具有低 表面張力之溶劑,塗佈於基板時,可提高塗膜均勻性,也 φ 可適用於本發明之液晶配向處理劑。其中,特別是從聚醯 亞胺之溶解性的觀點,較佳爲丁基溶纖素、乙基卡必醇、 二丙二醇單甲醚、二乙二醇二乙醚。 改善塗膜特性的添加物,例如有3-胺基丙基甲基二 甲氧基矽烷、3-苯基胺基丙基三甲氧基矽烷、3-胺基丙基 三乙氧基矽烷、(胺基乙基胺基甲基)苯乙基三甲氧基矽烷 等之矽烷偶合劑。藉由添加這些矽烷偶合劑’可提高對基 板之塗膜的密著性,但是添加過多時,聚醯胺酸或聚醯亞 胺等容易凝集。因此矽烷偶合劑之含量較佳爲對於聚醯胺 -29- 201030056 酸或聚醯亞胺之合計質量爲〇·5〜10質量%,更佳爲1~5質 量%。 本發明之液晶配向處理劑之固形分濃度,可依據欲形 成之液晶配向膜之厚度設定來適當變更,較佳爲1~10質 量%。未達1質量%時,很難形成均勻,且無缺陷的塗 膜,多於10質量%時,有時溶液之保存安定性變差。 又,固形分係指液晶配向處理劑中除去溶劑者。本發明之 液晶配向處理劑所使用之聚醯胺酸或聚醯亞胺之濃度無特 別限定,從所得之液晶配向膜特性的觀點,較佳爲1質量 %以上,更佳爲3質量%以上,特佳爲5質量%以上。 以上所得之液晶配向處理劑在塗佈於基板之前,進行 過濾較佳。 &lt;液晶顯示元件&gt; 本發明之液晶配向處理劑係塗佈於基板上,經乾燥、 燒成可形成塗膜,將此塗佈面以摩擦處理,可作爲摩擦用 之液晶配向膜使用。而也可作爲未摩擦處理之VA用(垂 直配向用)液晶配向膜、光配向膜使用。 此時使用的基板只要是透明性局的基板時,並無特別 限定,可使用玻璃基板、丙烯酸基板或聚碳酸酯基板等塑 膠基板等,使用形成液晶驅動用之ITO電極等的基板,從 製程簡單化的觀點而言較佳。又,反射型之液晶顯示元 件時,僅爲單側之基板的情形,也可使用矽晶圓等不透明 物,此時的電極也可使用反射鋁等光的材料。 -30- 201030056 液晶配向處理劑之塗佈方法例如有旋轉塗佈法、印刷 法、噴墨法等,從生產性方面,工業上廣泛使用凹版印刷 法,本發明之液晶配向處理劑也適用。 塗佈液晶配向處理劑後之乾燥步驟不一定需要,但是 塗佈後至燒成爲止的時間,各基板不固定時,或塗佈後未 隨即燒成時,含有乾燥步驟較佳。乾燥只要是基板之搬送 等,塗膜形狀不會變形之程度,溶劑產生蒸發即可,該乾 φ 燥手段無特別限定。具體例爲 50〜150°C,較佳爲 80~120°C之加熱板上,乾燥0.5~30分鐘,較佳爲1〜5分 鐘的方法。 塗佈液晶配向處理劑之基板的燒成可於100〜3 50°C之 任意溫度下進行,較佳爲 150°C~300°C ,更佳爲 1 8 0°C〜2 5 0 °C。又,液晶配向處理劑中含有醯胺酸基時, 藉由此燒成溫度,由醯胺酸轉變成醯亞胺之轉化率產生變 化,但是本發明之液晶配向處理劑不一定需要1 0 0 %醯亞 # 胺化。 燒成後之塗膜厚度,若過厚時,不利於液晶顯示元件 之消耗電力,若過薄時,有時液晶顯示元件之信賴性會降 低,因此較佳爲10〜200nm,更佳爲50〜l〇〇nm。 如上述,在基板上所形成之塗膜面的摩擦處理可使用 既有的摩擦裝置。此時之摩擦布的材質例如有棉、生絲、 尼龍等。 上述手法所得之附液晶配向膜的基板係以公知方法製 作液晶胞作爲液晶顯示元件。列舉液晶胞製作之一例時, -31 - 201030056 一般而言’較佳爲1〜30μηι,更佳爲2~10μιη之間隔物夾 緊1對形成液晶配向膜之基板,摩擦方向爲0〜2 7 0°之任意 角度而設置’周圍以密封劑固定,注入液晶後進行封閉的 方法。液晶封閉的方法無特別限定,例如有將製作後之液 晶晶胞減壓後,注入液晶之真空法、滴入液晶後進行封閉 之滴下(ODF)法等。 如此所得之液晶顯示元件適用於ΤΝ液晶顯示元件、 STN液晶顯示元件、TFT液晶顯示元件、OCB液晶顯示元 件、以及橫電場型(IPS)之液晶顯示元件、垂直配向(VA) 液晶顯示元件等各種方式的顯示元件。 【實施方式】 [實施例] 以下舉出實施例對本發明做更詳細說明,但本發明並 非限定於此且解釋者。 (合成例1)3,5-二胺基苄基呋喃-2-羧酸酯之合成 在500mL(毫升)之三口燒瓶中添加1,3-二硝基苄醇 25.0g、2-呋喃甲酸基氯10.5mL及四氫呋喃3〇〇mL。再滴 加吡啶9.0mL,室溫下攪拌25小時。反應終了後,添加 純水50mL攪拌1小時。添加乙酸乙酯萃取有機層,以 1N鹽酸、飽和碳酸氫鈉、飽和食鹽水洗淨有機層。接 著,有機層中添加無水硫酸鎂進行脫水乾燥’經過濾後, 使用旋轉式蒸發器餾除溶劑。將殘渣使用四氫呋喃/己烷 -32- 201030056 = 1/3(體積比,以下相同)進行再結晶,得到27.5g之乳白 色固體(收率93%)。此乳白色固體之1H-NMR之測定結果 如下所示。由此結果確認所得的固體爲目的之二硝基化合 物。此外,1H-NMR係指分子內氫原子之核磁共振光譜。 *H NMR (400 MHz « CDC13):59.04 (t,lH) » 8.66-8.63 (m,2H),7.65 (dd,lH),7.32 (dd,lH),6.58 (dd,lH),5.53 (s,2H)Among the "diamines of the batch", the diamine liquid crystal of the formula [1 2 ] is excellent in the alignment property of the liquid crystal. The diamine-based pretilt angle of the formula [I9] to [26] can be very high. Therefore, it is suitable for an aligning film for opaque CB (Optically Compensated Bend) (alignment film for OCB under -22-201030056), vertical alignment An alignment film for a mode liquid crystal (hereinafter referred to as an alignment film for VA). For example, when the alignment film of the TN liquid crystal (pretilt angle is 3 to 5°), the content of the diamine of the formula [12] is preferably 10 to 30 mol% of the entire diamine component, and the alignment film for OCB or the alignment film for VA. When the pretilt angle is 10 to 90°, the content of the diamine of the formula [19] to [26] is preferably 5 to 40 mol% of the entire diamine component, but is not limited thereto. φ In consideration of the balance between the solubility of polyphthalic acid or polyimine used in the liquid crystal alignment agent of the present invention, the alignment of liquid crystal, the tilt angle, the voltage holding ratio, and the accumulated charge, for example, When the diamine component represented by the formula [11] and the formula [12] is polymerized, the preferred ratio of the respective diamine components is expressed by the molar ratio, preferably from 1 to 50% (formula [ 1]) / 20 ~ 80% (form [11]) / 10 ~ 30% (form [12]), more preferably 20 ~ 40% / 3 0 ~ 50% / 10 ~ 3 0 〇 / 〇, but not Limited to this.四 <tetracarboxylic dianhydride component> The polycarboxylic acid or polyimine which is required for the liquid crystal alignment treatment agent of the present invention is not particularly limited as long as the tetracarboxylic dianhydride component which reacts with the above diamine component. In other words, it is possible to use two or more kinds of tetracarboxylic dianhydrides of one type of tetracarboxylic dianhydride or hydrazine. In the liquid crystal alignment agent of the present invention, the tetrahydro acid dianhydride which reacts with the diamine component is preferably a tetrahydro acid having an alicyclic structure or an aliphatic structure, from the viewpoint of further increasing the voltage holding ratio of the liquid crystal cell. Diacid anhydride. The four-residual acid dianhydride having an alicyclic structure or an aliphatic structure is, for example, -23-201030056 1,2,3,4-cyclobutanine tetraresidic acid di-hepatic, 1,2-dimethyl-1,2,3 , 4-cyclobutylene tetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1 , 2,3,4-cyclobutane tetracarboxylic dianhydride, 1,2,3,4-cyclopentane tetracarboxylic dianhydride, 2,3,4,5-tetrahydrofuran tetracarboxylic dianhydride, 1, 2,4,5-cyclohexanetetracarboxylic dianhydride, 3,4-dicarboxy-1-cyclohexyl succinic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydro-1 -naphthylsuccinic dianhydride, [4-(2,5-dioxotetrahydrofuran-3-yl)-1,2,3,4-tetrahydronaphthalene-1,2-dicarboxylic dianhydride], 1, 2,3,4-butane tetracarboxylic dianhydride, bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride, 3,3',4,4'-di Cyclohexyltetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentyl acetic acid dianhydride, cis-3,7-dibutylcyclooctane-1,5-diene-1,2,5,6 -carboxylic acid dianhydride, tricyclo[4.2.1.〇2,5]decane-3,4,7,8-tetracarboxylic acid-3,4:7,8-dianhydride,hexacyclo[6_6.0.12 , 7.03, 6.19, 14.010, 13] hexadecane-4,5,11,12-tetracarboxylic acid-4,5:11,12-dianhydride, and the like. Among them, in particular, when 1,2,3,4-cyclobutanetetracarboxylic dianhydride is used, an alignment film having excellent liquid crystal alignment property can be obtained, which is preferable. When an aromatic tetracarboxylic dianhydride is used, the liquid crystal alignment property can be improved, and the accumulated charge of the liquid crystal cell can be quickly eliminated. The aromatic tetracarboxylic dianhydride is, for example, pyromellitic dianhydride, 3,3',4,4,-biphenyltetracarboxylic dianhydride, 2,2',3,3'-biphenyltetracarboxylic acid Anhydride, 2,3,3',4-biphenyltetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 2,3,3',4-diphenyl Ketone tetracarboxylic dianhydride, bis(3,4-dicarboxyphenyl)ether dianhydride, bis(3,4.dicarboxyphenyl) succinic anhydride, 1,2,5,6-naphthalenetetracarboxylic acid Diacetic anhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, and the like. Among them, pyromellitic dianhydride is preferred. Considering the balance of the solubility of the obtained polyaminic acid or polyimine, the alignment of the liquid crystal, the voltage holding ratio, and the accumulated charge, the tetracarboxylic acid having an alicyclic structure or an aliphatic structure of -24 to 201030056 The use ratio of the acid dianhydride to the aromatic tetracarboxylic dianhydride is expressed by the former/the latter molar ratio, preferably 90/10 to 50/50, more preferably 80/20 to 60/40 ° &lt;polymerization Reaction&gt; In the present invention, the polymerization reaction method of the tetracarboxylic dianhydride component and the diamine component is not particularly limited. In general, the polymerization φ reaction is carried out by mixing in an organic solvent to obtain a poly-proline which can be converted into a polyimine by dehydration ring closure. A method of mixing a tetracarboxylic dianhydride component and a diamine component in an organic solvent, for example, a solution in which a diamine component is dispersed or dissolved in an organic solvent, and the tetracarboxylic dianhydride component is directly or dispersed or dissolved in a solution. In the method of adding an organic solvent, a method of adding a diamine component to a solution in which a tetracarboxylic dianhydride is dispersed or dissolved in an organic solvent, or a method of mutually adding a tetracarboxylic dianhydride and a diamine component, or the like. Further, when the tetracarboxylic dianhydride or the diamine is composed of a plurality of compounds, the plurality of components may be mixed in advance to carry out a polymerization reaction, or the polymerization may be carried out in sequence. The temperature at which the tetracarboxylic dianhydride component and the diamine component are polymerized in an organic solvent is usually 〇 150 ° C, preferably 5 to 100 ° C, more preferably 10 to 80 ° C. At higher temperatures, the polymerization reaction ends quickly, but when it is too high, high molecular weight polymers are sometimes not obtained. The polymerization reaction can be carried out at any concentration. However, when the total concentration of the tetracarboxylic dianhydride component and the diamine component is too low, it is difficult to obtain a polymer having a high molecular weight. When the concentration is too high, the viscosity of the reaction solution is too high. Difficult, because -25- 201030056 The total concentration is preferably from 1 to 50% by mass, more preferably from 5 to 30% by mass. The initial stage of the polymerization reaction is carried out at a high concentration, and thereafter an organic solvent may be added. The organic solvent used in the above polymerization reaction is not particularly limited as long as it is a polylysine which can be produced by dissolution. Specific examples thereof are N,N'-dimethylformamide, guanidine, Ν'-dimethylacetamide, N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, oxime-methyl Caprolactam, dimethyl hydrazine, tetramethyl urea, pyridine, dimethyl maple, hexamethyl yam, yttrium-butyrolactone, 1,3-dimethylimidazolidinone and the like. These can be used alone or in combination. Even if it is a solvent which does not dissolve poly-proline, it can be mixed with the above-mentioned solvent in the range which does not isolate|separate the produced poly- amic acid. Further, since the water in the organic solvent hinders the polymerization reaction and also causes hydrolysis of the produced polylysine, the organic solvent is used as far as possible for dehydration. The ratio of the tetracarboxylic dianhydride component to the diamine component used in the polymerization of polylysine is expressed by a molar ratio, preferably 1:0.8 to 1:1.2, and the molar ratio is closer to 1:1. The greater the molecular weight of polylysine. Controlling the molecular weight of the polyamine can adjust the molecular weight of the resulting polyimine after the imidization. The molecular weight of the polyaminic acid or the polyimine of the present invention is not particularly limited, and is contained in the liquid crystal alignment treatment agent, from the viewpoint of the strength of the obtained coating film and the ease of handling as a liquid crystal alignment treatment agent. The average molecular weight means preferably 2,000 to 200, 〇00, more preferably 5,000 to 50,000. &lt;Synthesis of Polyimine&gt; The polyimine used in the liquid crystal alignment treatment agent of the present invention is a polyimine which is arniminated by the above-mentioned -26-201030056 polyamine. The ruthenium imidization of polyglycolic acid is carried out in an organic solvent in the presence of a basic catalyst and an acid anhydride by stirring for 1 to 100 hours. The basic catalyst is, for example, pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine or the like. Among them, pyridine has a moderate basicity required for carrying out the reaction, and therefore is preferred. Further, the acid anhydride may, for example, be acetic anhydride, trimellitic anhydride, benzene tetracarboxylic anhydride Φ or the like. Among them, acetic anhydride is preferred because the purification of the obtained polyimine is easy after the imidization of hydrazine. As the organic solvent, the solvent used in the polymerization of the aforementioned polyaminic acid can be used. The imidization ratio of the polyimine can be controlled by adjusting the amount of the catalyst, the reaction temperature, the reaction time, and the like. The amount of the alkaline catalyst at this time is preferably from 0.2 to 10 moles, more preferably from 0.5 to 5 moles, per mole of the amidoxime group. The amount of the acid anhydride is preferably from 1 to 30 moles, more preferably from 1 to 10 moles, per mole of the amidate group. The reaction temperature is preferably from -20 ° C to 250 ° C, more preferably from 0 ° C to 180 ° C. φ The ruthenium imidization ratio of the polyimine used in the liquid crystal alignment treatment agent of the present invention is not particularly limited, but the ruthenium imidation ratio is preferably 40 from the reason that a liquid crystal alignment film having a higher voltage retention ratio can be obtained. More than %, more preferably 60% or more, and particularly preferably more than 80%. In the solution of the polyimine obtained as described above, since the catalyst or the like after the addition remains, it is preferred to use the polyimine after the liquid crystal alignment agent is recovered and washed. The recovery of the polyimine is carried out by stirring the solution of the ruthenium iodide into a stirred weak solvent to precipitate the polyimine. The weak solvent at this time -27- 201030056 Examples include methanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, and the like. This weak solvent can also be used for the washing of the recovered polyimine. The polyimine thus recovered and washed can be dried at normal temperature or under reduced pressure at normal temperature or under reduced pressure. This operation can also be carried out for the aforementioned polylysine. For example, when the liquid crystal alignment agent does not contain a solvent for polymerization of poly-proline, or when unreacted monomers or impurities in the reaction solution are to be removed, the above-described precipitation recovery and purification may be carried out. &lt;Liquid Crystal Alignment Treatment Agent&gt; The liquid crystal alignment treatment agent of the present invention contains a coating liquid selected from at least one of the polyamic acid and the polyimine obtained as described above. The production example is that the reaction solution of the above polyamic acid or polyimine is directly or diluted, or the reaction liquid is re-dissolved in an organic solvent by precipitation. In the step of diluting or redissolving, the solvent composition for controlling the coatability of the substrate or the addition of an additive for improving the film properties can be adjusted. It is also possible to mix or add other resin components to the polyimine solution or the polyaminic acid solution of the above different structure. The organic solvent to be used in the above-mentioned dilution or redissolution step is not particularly limited as long as it is a polymer to be dissolved. Specific examples thereof are N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone, N- Ethyl-2-pyrrolidone, N-vinylpyrrolidone, dimethyl hydrazine, tetramethyl urea, dimethyl hydrazine, hexamethyl argon, r-butyrolactone, 1,3-dimethyl-imidazole Linoleone and the like. Among them, -28-201030056 is preferably N-methyl-2-indolyl ketone, N-ethyl-2-indole fluorenone, iota, 3-dimethyl-imidazolidinone, γ-butane ester. These may be used alone or in combination of two or more. The solvent used for controlling the applicability of the liquid crystal alignment agent to the substrate is, for example, ethyl cellosolve, butyl cellosolve, ethyl carbitol, butyl carbitol, ethyl carbitol acetate , ethylene glycol, 1-methoxy-2-propanol, ethoxylated 2-propanol, 1-butoxy-2-propanol, 1-phenoxy-2-propanol, two Ethylene glycol diethyl ether, propylene glycol monoacetate, propylene glycol diacetate, dipropylene glycol monomethyl ether, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl ether-2_acetate Dipropylene glycol, 2-(2-ethoxypropoxy)propanol, methyl lactate, ethyl lactate, n-propyl lactate, n-butyl lactate, isoamyl lactate, and the like. These solvents also contain a solvent which cannot dissolve polyphosphoric acid or polyimine alone, but may be mixed with the liquid crystal alignment agent of the present invention insofar as the polymer does not precipitate. In particular, when a solvent having a low surface tension is appropriately mixed and applied to a substrate, the uniformity of the coating film can be improved, and φ can be suitably applied to the liquid crystal alignment treatment agent of the present invention. Among them, in particular, from the viewpoint of solubility of polyimine, butyl cellosolve, ethyl carbitol, dipropylene glycol monomethyl ether, and diethylene glycol diethyl ether are preferred. Additives for improving coating film properties include, for example, 3-aminopropylmethyldimethoxydecane, 3-phenylaminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, A decane coupling agent such as aminoethylaminomethylmethyl)phenethyltrimethoxydecane. The adhesion to the coating film of the substrate can be improved by adding these decane coupling agents. However, when too much is added, polyglycine or polyimine or the like tends to aggregate. Therefore, the content of the decane coupling agent is preferably 〇·5 to 10% by mass, more preferably 1 to 5% by mass, based on the total mass of the polyamine -29-201030056 acid or polyimine. The solid content concentration of the liquid crystal alignment agent of the present invention can be appropriately changed depending on the thickness setting of the liquid crystal alignment film to be formed, and is preferably 1 to 10% by mass. When the amount is less than 1% by mass, it is difficult to form a uniform and defect-free coating film. When the content is more than 10% by mass, the storage stability of the solution may be deteriorated. Further, the solid fraction refers to a solvent in which a solvent is removed from the liquid crystal alignment treatment agent. The concentration of the polyamic acid or the polyimine used in the liquid crystal alignment agent of the present invention is not particularly limited, and is preferably 1% by mass or more, and more preferably 3% by mass or more from the viewpoint of the characteristics of the obtained liquid crystal alignment film. , particularly preferably 5 mass% or more. The liquid crystal alignment treatment agent obtained above is preferably filtered before being applied to a substrate. &lt;Liquid crystal display element&gt; The liquid crystal alignment treatment agent of the present invention is applied onto a substrate, dried, and fired to form a coating film, and the coated surface is rubbed to be used as a liquid crystal alignment film for rubbing. Further, it can also be used as a liquid crystal alignment film or a light alignment film for VA (for vertical alignment) which is not rubbed. The substrate to be used in this case is not particularly limited as long as it is a transparent substrate. A plastic substrate such as a glass substrate, an acrylic substrate or a polycarbonate substrate can be used, and a substrate such as an ITO electrode for driving a liquid crystal can be used. It is preferred from the standpoint of simplification. Further, in the case of a reflective liquid crystal display element, it is only a single-sided substrate, and an opaque such as a germanium wafer may be used. In this case, a material that reflects light such as aluminum may be used as the electrode. -30-201030056 The coating method of the liquid crystal alignment agent is, for example, a spin coating method, a printing method, an inkjet method, or the like. From the viewpoint of productivity, the gravure printing method is widely used in the industry, and the liquid crystal alignment treatment agent of the present invention is also applicable. The drying step after the application of the liquid crystal alignment agent is not necessarily required, but the drying step is preferably carried out when the substrate is not fixed, or when the substrate is not fixed, or is not immediately baked after coating. The drying is not particularly limited as long as the substrate is conveyed or the like, and the shape of the coating film is not deformed, and the solvent is evaporated. The specific example is a method of drying on a hot plate of 50 to 150 ° C, preferably 80 to 120 ° C, for 0.5 to 30 minutes, preferably 1 to 5 minutes. The baking of the substrate coated with the liquid crystal alignment agent can be carried out at any temperature of 100 to 3 50 ° C, preferably 150 ° C to 300 ° C, more preferably 180 ° C to 2 5 0 ° C. . Further, when the liquid crystal alignment agent contains a proline group, the conversion ratio of the proline to the quinone is changed by the firing temperature, but the liquid crystal alignment agent of the present invention does not necessarily need to be 100. %醯亚# Amination. When the thickness of the coating film after firing is too thick, power consumption of the liquid crystal display element is disadvantageous. When the thickness is too thin, the reliability of the liquid crystal display element may be lowered. Therefore, it is preferably 10 to 200 nm, more preferably 50. ~l〇〇nm. As described above, the rubbing treatment of the coating film surface formed on the substrate can use an existing friction device. The material of the rubbing cloth at this time is, for example, cotton, raw silk, nylon, or the like. The substrate to which the liquid crystal alignment film obtained by the above method is formed is a liquid crystal cell as a liquid crystal display element by a known method. When one example of liquid crystal cell production is cited, -31 - 201030056 Generally, a spacer of preferably 1 to 30 μm, more preferably 2 to 10 μm, is clamped to a substrate on which a liquid crystal alignment film is formed, and the rubbing direction is 0 to 2 7 At any angle of 0°, a method of fixing the periphery with a sealant and injecting the liquid crystal to perform sealing is provided. The method of sealing the liquid crystal is not particularly limited. For example, there is a vacuum method in which a liquid crystal cell after production is decompressed, a vacuum method in which a liquid crystal is injected, and a dropping (ODF) method in which a liquid crystal is dropped and then closed. The liquid crystal display element thus obtained is suitable for use in various liquid crystal display elements, STN liquid crystal display elements, TFT liquid crystal display elements, OCB liquid crystal display elements, liquid crystal display elements of transverse electric field type (IPS), vertical alignment (VA) liquid crystal display elements, and the like. Display element of the mode. [Embodiment] [Examples] Hereinafter, the present invention will be described in more detail with reference to examples but the present invention is not limited thereto. (Synthesis Example 1) Synthesis of 3,5-diaminobenzylfuran-2-carboxylate In a 500 mL (ml) three-necked flask, 25.0 g of 1,3-dinitrobenzyl alcohol and 2-furancarboxylic acid group were added. 10.5 mL of chlorine and 3 mL of tetrahydrofuran. Further, 9.0 mL of pyridine was added dropwise, and the mixture was stirred at room temperature for 25 hours. After the completion of the reaction, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Subsequently, anhydrous magnesium sulfate was added to the organic layer to carry out dehydration drying. After filtration, the solvent was distilled off using a rotary evaporator. The residue was recrystallized using tetrahydrofuran/hexane-32-201030056 = 1/3 (volume ratio, the same below) to obtain 27.5 g of a white solid (yield: 93%). The results of 1H-NMR measurement of this milky white solid are shown below. From this result, it was confirmed that the obtained solid was the intended dinitro compound. Further, 1H-NMR refers to a nuclear magnetic resonance spectrum of a hydrogen atom in a molecule. *H NMR (400 MHz « CDC13): 59.04 (t,lH) » 8.66-8.63 (m,2H), 7.65 (dd,lH),7.32 (dd,lH),6.58 (dd,lH),5.53 (s , 2H)

[化 18][Chem. 18]

接著,於5 OOmL之四口燒瓶中添加二硝基化合物 2 3.8g、鉑/碳(質量比爲1/1〇,以下相同)2.4g及甲醇 2 3 9g,氫氣氛下,攪拌43小時。反應終了後,進行矽藻 土過濾,使用旋轉式蒸發器餾除溶劑。殘渣使用異丙醇進 行再結晶,得到16.1g的淡橙色固體(收率85%)。 此淡茶色固體之1Η-NMR的測定結果如下所示。由此 結果確認所得之淡橙色固體爲目的之二胺。 1H NMR (400 MHz,CDC13):57.58 (dd,lH),7_21 (dd,lH),6.51 (dd,lH),6.18 (dt,2H),6.00 (t,lH),5.16 (s,2H),3.62 (br,4H) -33- 201030056 [化 19]Next, 3.8 g of a dinitro compound 2, a platinum/carbon (mass ratio of 1/1 Torr, the same below), 2.4 g of methanol and 23.9 g of methanol were added to a 500 mL four-necked flask, and the mixture was stirred for 43 hours under a hydrogen atmosphere. After the completion of the reaction, the mixture was filtered through Celite, and the solvent was distilled off using a rotary evaporator. The residue was recrystallized using isopropyl alcohol to give 16.1 g of pale orange solid (yield: 85%). The results of 1 Η-NMR measurement of this pale brown solid are shown below. From this result, it was confirmed that the obtained pale orange solid was the intended diamine. 1H NMR (400 MHz, CDC13): 57.58 (dd, lH), 7_21 (dd, lH), 6.51 (dd, lH), 6.18 (dt, 2H), 6.00 (t, lH), 5.16 (s, 2H) , 3.62 (br, 4H) -33- 201030056 [Chem. 19]

(合成例2)呋喃-2-基甲基3,5-二胺基苯甲酸酯之合成 於500mL之四口燒瓶中添加3,5-二硝基苯甲醯基氯 25.3g、呋喃醇 lO.OmL及四氫呋喃200mL。再滴加吡啶 9.7mL,室溫下攪拌 16小時。反應終了後,添加純水 5 OmL攪拌1小時。添加乙酸乙酯萃取有機層,以1N鹽 酸、飽和碳酸氫鈉、飽和食鹽水洗淨有機層。於有機層中 添加無水硫酸鎂進行脫水乾燥,經過濾後,使用旋轉式蒸 發器餾除溶劑。將殘渣藉由矽凝膠柱色譜(餾出溶劑爲己 烷:乙酸乙酯=3:1之混合溶劑)純化,得到30.3g之二硝基 化合物(收率95%)。所得之固體以1H-NMR所測定的結果 如下所示。由此結果確認所得之固體爲目的之二硝基化合 物。 *H NMR (400 MHz,CDC13):69.23 (t,lH),9.17 (d,2H),7·49 (dd,lH),6.57 (dd,lH),6.43 (dd,lH),5.44 (s,2H) [化 20](Synthesis Example 2) Synthesis of furan-2-ylmethyl 3,5-diaminobenzoic acid ester In a 500 mL four-necked flask, 25.3 g of 3,5-dinitrobenzimidyl chloride and furanol were added. lO.OmL and tetrahydrofuran 200mL. Further, 9.7 mL of pyridine was added dropwise, and the mixture was stirred at room temperature for 16 hours. After the completion of the reaction, 5 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Anhydrous magnesium sulfate was added to the organic layer to conduct dehydration drying, and after filtration, the solvent was distilled off using a rotary evaporator. The residue was purified by silica gel column chromatography (dichloroacetic acid: ethyl acetate = 3:1) to afford 30.3 g of dinitro compound (yield 95%). The results of 1H-NMR measurement of the obtained solid are shown below. From this result, it was confirmed that the obtained solid was the intended dinitro compound. *H NMR (400 MHz, CDC13): 69.23 (t, lH), 9.17 (d, 2H), 7.49 (dd, lH), 6.57 (dd, lH), 6.43 (dd, lH), 5.44 (s , 2H) [Chem. 20]

201030056 接著,於 500mL之四口燒瓶中添加二硝基化合物 30.3g'鉑/碳3.1g及甲醇400mL,氫氣氛下,以室溫攪 拌。反應終了後,進行矽藻土過濾,使用旋轉式蒸發器餾 除溶劑。殘渣使用異丙醇/己烷=1/1進行再結晶,得到 1 1.6g的淡茶色固體(收率48%)。 此淡茶色固體之1H-NMR的測定結果如下所示。由此 結果確認所得之淡茶色固體爲目的之二胺。 lH NMR (400 MHz,DMSO-d6):57.71 (dd, 1 Η) &gt; 6.57 (dd,lH) &gt; 6.48 (dd,2H),6.4 1 (d,2H),6.01 (t,lH),5.20 (s,2H),5.02 (br,4H) [化 21] o2n201030056 Next, a dinitro compound 30.3 g of platinum/carbon 3.1 g and methanol (400 mL) were placed in a 500 mL four-necked flask, and the mixture was stirred at room temperature under a hydrogen atmosphere. After the completion of the reaction, the mixture was filtered through Celite, and the solvent was distilled off using a rotary evaporator. The residue was recrystallized using isopropyl alcohol / hexane = 1 / 1 to give 1 1.6 g of pale brown solid (yield: 48%). The results of 1H-NMR measurement of this pale brown solid are shown below. From this result, it was confirmed that the obtained pale brown solid was the intended diamine. lH NMR (400 MHz, DMSO-d6): 57.71 (dd, 1 Η) &gt; 6.57 (dd, lH) &gt; 6.48 (dd, 2H), 6.4 1 (d, 2H), 6.01 (t, lH), 5.20 (s, 2H), 5.02 (br, 4H) [Chem. 21] o2n

(合成例3)N-(3,5-二胺基苯基)呋喃-2-甲醯胺之合成 於5 00mL三口燒瓶中添加3,5-二硝基苯胺24.lg、吡 啶11.7mL及四氫呋喃300mL,再滴加2-呋喃甲醯基氯 1 3.8mL,室溫下攪拌1 8小時。反應終了後,添加純水 50mL攪拌1小時。添加乙酸乙酯萃取有機層,以1N鹽 酸、飽和碳酸氫鈉、飽和食鹽水洗淨有機層。接著,有機 層中添加無水硫酸鎂進行脫水乾燥,經過濾後,使用旋轉 式蒸發器餾除溶劑。將殘渣使用四氫呋喃/己烷=1/3進行 再結晶,得到31. lg之二硝基化合物(收率85%)。所得之 -35- 201030056 固體之1 H-NMR之測定結果如下所示。由此結果確認所得 的固體爲目的之二硝基化合物。 !H NMR (400 MHz,DMSO-d6):51 1 .1 (s,lH),9_11 (d,2H),8.54 (t,lH),8_05 (dd,lH),7_46 (dd’lH) ’ 6.78 (dd, 1 Η) [化 22](Synthesis Example 3) Synthesis of N-(3,5-diaminophenyl)furan-2-carboxamide A 3,5-dinitroaniline 24.lg and pyridine 11.7 mL were added to a 500 mL three-necked flask. 300 mL of tetrahydrofuran was added dropwise to 3.8 mL of 2-furoylmethyl chloride, and the mixture was stirred at room temperature for 18 hours. After the completion of the reaction, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Next, anhydrous magnesium sulfate was added to the organic layer to carry out dehydration drying, and after filtration, the solvent was distilled off using a rotary evaporator. The residue was recrystallized from tetrahydrofuran / hexane = 1/3 to give 31. lg of dinitro compound (yield: 85%). The results of the measurement of 1 H-NMR of the solid -35-201030056 obtained are shown below. From this result, it was confirmed that the obtained solid was the intended dinitro compound. !H NMR (400 MHz, DMSO-d6): 51 1 .1 (s, lH), 9_11 (d, 2H), 8.54 (t, lH), 8_05 (dd, lH), 7_46 (dd'lH) ' 6.78 (dd, 1 Η) [Chem. 22]

接著,於 1L之四口燒瓶中添加二硝基化合物 30.9g、鉑/碳4.2g、1,4-二噁烷300g及四氫呋喃800g, 氫氣氛下進行。反應終了後,進行矽藻土過濾,使用旋轉 式蒸發器餾除溶劑。殘渣使用異丙醇進行再結晶,得到淡 茶色固體21.4g(收率89%)。 此淡茶色固體之1Η-NMR的測定結果如下所示。由此 © 結果確認所得之淡茶色固體爲目的之二胺。 NMR (400 MHz,DMSO-d6):59.5 1 (s,lH),7.87 (dd,lH),7.28 (dd,lH),6.65 (dd,lH),6.23 (d,2H),5.60 (t,lH),4.73 (br,4H) -36- 201030056 [化 23] ο2ν ΟNext, 30.9 g of a dinitro compound, 4.2 g of platinum/carbon, 300 g of 1,4-dioxane, and 800 g of tetrahydrofuran were placed in a four-liter four-necked flask under a hydrogen atmosphere. After the completion of the reaction, the mixture was filtered through Celite, and the solvent was distilled off using a rotary evaporator. The residue was recrystallized from isopropyl alcohol to give 21.4 g (yield: 89%) of pale brown solid. The results of 1 Η-NMR measurement of this pale brown solid are shown below. From this, it was confirmed that the obtained pale brown solid was the intended diamine. NMR (400 MHz, DMSO-d6): 59.5 1 (s,lH), 7.78 (dd,lH), 7.28 (dd,lH), 6.65 (dd,lH), 6.23 (d,2H), 5.60 (t, lH), 4.73 (br, 4H) -36- 201030056 [化23] ο2ν Ο

Ν〇2Ν〇2

Η2 R/C 1,4-Dioxane, THFΗ2 R/C 1,4-Dioxane, THF

(合成例4) 3,5-二胺基苄基噻吩-2-羧酸酯(DABTh)之 合成 φ 在500mL(毫升)之三口燒瓶中添加3,5-二硝基苄醇 21.5g、2-噻吩甲醯基氯12.1mL及四氫呋喃200mL。再滴 加吡啶9.6mL,室溫下攪拌48小時。反應終了後,添加 純水5〇mL攪拌1小時。添加乙酸乙酯萃取有機層,以 1N鹽酸、飽和碳酸氫鈉、飽和食鹽水洗淨有機層。接 著,有機層中添加無水硫酸鎂進行脫水乾燥,經過濾後, 使用旋轉式蒸發器餾除溶劑。將殘渣使用乙酸乙酯與己烷 進行再結晶,得到2 7 · 5 g之二硝基化合物(收率8 2 %)。以 ® 下表示所得之固體之1H-NMR之測定結果。 NMR (400 MHz, C DC 13): δ 9.0 3 (t, 1H) » 8.66-8.63 (m, 2H),7.90(dd, 1H),7.66 (dd, 1H),7.17 (dd, 1H), 5.52 (s, 2H) -37- 201030056 [化 24](Synthesis Example 4) Synthesis of 3,5-diaminobenzylthiophene-2-carboxylate (DABTh) φ In a 500 mL (ml) three-necked flask, 2,5-dinitrobenzyl alcohol 21.5 g, 2 was added. - 12.1 mL of thiophenemethyl chloride and 200 mL of tetrahydrofuran. Further, 9.6 mL of pyridine was added dropwise, and the mixture was stirred at room temperature for 48 hours. After the completion of the reaction, 5 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Subsequently, anhydrous magnesium sulfate was added to the organic layer to carry out dehydration drying, and after filtration, the solvent was distilled off using a rotary evaporator. The residue was recrystallized from ethyl acetate and hexane to give 2,7 g of dinitro compound (yield: 82%). The results of 1H-NMR measurement of the obtained solid are indicated by ® . NMR (400 MHz, C DC 13): δ 9.0 3 (t, 1H) » 8.66-8.63 (m, 2H), 7.90 (dd, 1H), 7.66 (dd, 1H), 7.17 (dd, 1H), 5.52 (s, 2H) -37- 201030056 [Chem. 24]

17.5g、鈾/碳4.3g及四氫呋喃200g,氫氣氛下 小時。反應終了後,進行矽藻土過濾,使用旋轉 餾除溶劑。殘渣使用四氫呋喃與異丙醇進行再結 淡茶色固體12.9g(收率92%)。 此淡茶色固體之1H-NMR的測定結果如下戶ϋ 結果確認所得之淡茶色固體爲目的之二胺。 'Η NMR (400 MHz, C D C13) : δ 7.8 3 (dd, 1H) · 1H) &gt; 7.10 (dd, 1H),6.19-6.17 (m, 2H) &gt; 6.00 5.16 (s,2H),3.61 (br,4H) 基化合物 ,攪拌48 式蒸發器 晶,得到 示。由此 7.56 (dd, (t, 1H), [化 25]17.5 g, uranium/carbon 4.3 g and tetrahydrofuran 200 g, under an atmosphere of hydrogen. After the completion of the reaction, the mixture was filtered through Celite, and the solvent was distilled off using rotary. The residue was subjected to a pale brown solid (12.9 g (yield: 92%) using tetrahydrofuran and isopropyl alcohol. The results of 1H-NMR measurement of the pale brown solid were as follows. 'Η NMR (400 MHz, CD C13) : δ 7.8 3 (dd, 1H) · 1H) &gt; 7.10 (dd, 1H), 6.19-6.17 (m, 2H) &gt; 6.00 5.16 (s, 2H), 3.61 The (br, 4H)-based compound was stirred in a 48-evaporator crystal to give the product. Thus 7.56 (dd, (t, 1H), [Chem. 25]

-2-羧酸酯 (合成例 5) 3,5-二胺基苄基-5-甲基呋喃 (MeDABFr)之合成 201030056 在500mL之四口燒瓶中添加5-甲基-2-呋喃羧酸8.5g 及二氯甲烷17〇mL,由室溫冷卻至〇°C。接著,添加乙二 醯氯5.9mL、及DMF0.5g,室溫下攪拌2小時。攪拌後, 添加3,5-二硝基苄醇I3.4g及吡啶6mL,室溫下攪拌16 小時。反應終了後,添加純水50mL攪拌1小時。添加乙 酸乙酯萃取有機層,以1N鹽酸、飽和碳酸氫鈉、飽和食 鹽水洗淨有機層。接著,有機層中添加無水硫酸鎂進行脫 φ 水乾燥,經矽藻土過濾後,使用旋轉式蒸發器餾除溶劑。 使用異丙醇洗淨殘渣,得到17.1g之二硝基化合物(收率 8 6%)。以下表示所得之固體之1H NMR的測定結果。 *Η NMR (400 MHz, CDC13):59.02 (t, 1H)- 8.65-8.62 (m,2H),7_23-7.21(m,lH),6.20-6.18(m,lH),5.52-5.50 (m,2H),2.43-2.41 (m, 3H) [化 26]2-Carboxylic ester (Synthesis Example 5) Synthesis of 3,5-diaminobenzyl-5-methylfuran (MeDABFr) 201030056 Addition of 5-methyl-2-furancarboxylic acid to a 500 mL four-necked flask 8.5 g and 17 mL of dichloromethane were cooled from room temperature to 〇 ° C. Next, 5.9 mL of ethylene dichloride and 0.5 g of DMF were added, and the mixture was stirred at room temperature for 2 hours. After stirring, 3,5-dinitrobenzyl alcohol I3.4 g and 6 mL of pyridine were added, and the mixture was stirred at room temperature for 16 hours. After the completion of the reaction, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Next, anhydrous magnesium sulfate was added to the organic layer to remove water, and the mixture was filtered through celite, and then the solvent was distilled off using a rotary evaporator. The residue was washed with isopropyl alcohol to obtain 17.1 g of a dinitro compound (yield: 6%). The measurement results of 1H NMR of the obtained solid are shown below. *Η NMR (400 MHz, CDC13): 59.02 (t, 1H)- 8.65-8.62 (m, 2H), 7_23-7.21 (m, lH), 6.20-6.18 (m, lH), 5.52-5.50 (m, 2H), 2.43-2.41 (m, 3H) [Chem. 26]

於500mL之四口燒瓶中添加一硝基化合物16.7g、鉑 /碳1.7g及四氫呋喃l7〇g,氫氣氛下’攪拌21小時。反 應終了後,進行矽藻土過濾’使用旋轉式蒸發器餾除溶 劑。使用異丙醇進行殘遼之再結晶’得到淡茶色固體 9.1 g(收率 68%)。 -39- 201030056 此淡茶色固體之1η-nmr的測定結果如下所示。由此 結果確認所得之淡茶色固體爲目的之二胺。 *H NMR (400 MHz, CDC13):67.15 (d, 2H) &gt; 7.10 (d, 1H),6.11-6.09 (m, 1H),5.97 (t,1H),5.13 (s,2H), 3.57 (br, 4H) &gt; 2.37 (s, 3H) [化 27]To a 500 mL four-necked flask, 16.7 g of a mononitro compound, 1.7 g of platinum/carbon and 17 g of tetrahydrofuran were added, and the mixture was stirred under a hydrogen atmosphere for 21 hours. After the reaction was completed, the diatomaceous earth was filtered. The solvent was distilled off using a rotary evaporator. Recrystallization of the residue was carried out using isopropyl alcohol to give a pale brown solid 9.1 g (yield 68%). -39- 201030056 The measurement results of 1η-nmr of this pale brown solid are as follows. From this result, it was confirmed that the obtained pale brown solid was the intended diamine. *H NMR (400 MHz, CDC13): 67.15 (d, 2H) &gt; 7.10 (d, 1H), 6.11-6.09 (m, 1H), 5.97 (t, 1H), 5.13 (s, 2H), 3.57 ( Br, 4H) &gt; 2.37 (s, 3H) [27]

(合成例6) 3,5-二胺基苄基呋喃-3-羧酸酯(3-DABFr) 之合成 在500mL之四口燒瓶中添加3-呋喃羧酸8.2g及二氯 甲烷240mL,由室溫冷卻至〇°C。接著,添加乙二醯氯 6.4mL及DMF0.5g,室溫下攪拌2小時。攪拌後,添加 3,5-二硝基苄醇15g及吡啶9.7mL,室溫下攪拌47小時。 反應終了後,添加純水50mL攪拌1小時。添加乙酸乙酯 萃取有機層,以1N鹽酸、飽和碳酸氫鈉、飽和食鹽水洗 淨有機層。接著,有機層中添加無水硫酸鎂進行脫水乾 燥,經過濾後,使用旋轉式蒸發器餾除溶劑。使用乙酸乙 酯進行殘渣之再結晶,得到16.8g之二硝基化合物(收率 7 8 %)。以下表示所得之固體之1 η N M R的測定結果。 *Η NMR (400 MHz, C D C13) : δ 9.0 3 (t, 1H) &gt; 8.63-8.61 201030056 (m,2H),8.12 (dd, 1H),7.4 1 (dd,1H),6.79 (dd,1H), 5.48(d, 2H) [化 28](Synthesis Example 6) Synthesis of 3,5-diaminobenzylfuran-3-carboxylate (3-DABFr) To a 500 mL four-necked flask, 8.2 g of 3-furancarboxylic acid and 240 mL of dichloromethane were added. Cool to 〇 ° C at room temperature. Next, 6.4 mL of ethylene dichloride and 0.5 g of DMF were added, and the mixture was stirred at room temperature for 2 hours. After stirring, 15 g of 3,5-dinitrobenzyl alcohol and 9.7 mL of pyridine were added, and the mixture was stirred at room temperature for 47 hours. After the completion of the reaction, 50 mL of pure water was added and stirred for 1 hour. The organic layer was extracted with ethyl acetate, and the organic layer was washed with 1N hydrochloric acid, saturated sodium hydrogen carbonate and brine. Next, anhydrous magnesium sulfate was added to the organic layer to carry out dehydration and drying, and after filtration, the solvent was distilled off using a rotary evaporator. Recrystallization of the residue using ethyl acetate gave 16.8 g of a dinitro compound (yield 78%). The measurement results of 1 η N M R of the obtained solid are shown below. *Η NMR (400 MHz, CD C13) : δ 9.0 3 (t, 1H) &gt; 8.63-8.61 201030056 (m, 2H), 8.12 (dd, 1H), 7.4 1 (dd, 1H), 6.79 (dd, 1H), 5.48(d, 2H) [28]

於500mL之四口燒瓶中添加二硝基化合物16.5g、鉑 /碳1.7g及四氫呋喃165g,氫氣氛下’攪拌29小時。反 應終了後,進行矽藻土過濾’使用旋轉式蒸發器餾除溶 劑。使用四氫呋喃與異丙醇進行殘渣之再結晶,得到淡茶 色固體7.4g(收率57%)。 此淡茶色固體之1 Η - N M R的測定結果如下所示。由此 結果確認所得之淡茶色固體爲目的之二胺。 Φ *H NMR (400 MHz, CDC13):58.04 (dd, 1H) » 7.42 (dd, 1H) , 6.77 (dd,1H),6.14 (d,2H),5.98 (t,1H),5.10 (s, 2H),3.57 (br, 4H) [化 29]To a 500 mL four-necked flask, 16.5 g of a dinitro compound, 1.7 g of platinum/carbon, and 165 g of tetrahydrofuran were added, and the mixture was stirred under a hydrogen atmosphere for 29 hours. After the reaction was completed, the diatomaceous earth was filtered. The solvent was distilled off using a rotary evaporator. Recrystallization of the residue using tetrahydrofuran and isopropanol gave 7.4 g (yield: 57%) of pale brown solid. The measurement results of 1 Η - N M R of this pale brown solid are as follows. From this result, it was confirmed that the obtained pale brown solid was the intended diamine. Φ *H NMR (400 MHz, CDC13): 58.04 (dd, 1H) » 7.42 (dd, 1H), 6.77 (dd, 1H), 6.14 (d, 2H), 5.98 (t, 1H), 5.10 (s, 2H), 3.57 (br, 4H) [Chem. 29]

-41 - 201030056 聚醯胺酸及聚醯亞胺之合成等所使用之化合物的簡稱 如下述。 &lt;四羧酸二酐&gt; CBDA:1,2,3,4-環丁烷四羧酸二酐 TDA:3,4-二羧基-1,2,3,4_四氫-1-萘琥珀酸二酐 &lt;二胺&gt; 2- DABFr:3,5-二胺基苄基呋喃-2-羧酸酯 FrDAB:呋喃-2-基甲基3,5-二胺基苯甲酸酯 DAAFr:N-(3,5-二胺基苯基)呋喃-2-甲醯胺 DABTh:3,5-二胺基苄基噻吩-2-羧酸酯 MeDABFr:3,5-二胺基苄基-5-甲基呋喃-2-羧酸酯 3- DABFr3,5-二胺基苄基呋喃-3-羧酸酯 Me4APhA:4-胺基-N-甲基苯乙胺 p-PDA:p-苯二胺 DDM:4,4’-二胺基二苯基甲烷 C14DAB:4-十四氧基-1,3-二胺基苯 C16DAB:4-十六氧基-1,3-二胺基苯 3-ABA:3-胺基苄胺 &lt;有機溶劑&gt; NMP:N-甲基-2·吡咯烷酮 γ-ΒΙ^:γ-丁內醋 BC:丁基溶纖素 DPM:二丙二醇單甲醚 201030056 DMF:二甲基甲醯胺 &lt;分子量之測定&gt; 藉由聚合反應所得之聚醯胺酸或聚醯亞胺的分子量係 藉由GPC(常溫凝膠滲透層析)裝置,以聚乙二醇及聚乙烯 氧化物換算値表示,計算得到數平均分子量與重量平均分 子量。 _ GPC 裝置:Shodex 公司製(GPC-101) 管柱:Shodex公司製管柱(KD-803、KD-805之直列)-41 - 201030056 The abbreviations of the compounds used in the synthesis of polyaminic acid and polyimine are as follows. &lt;tetracarboxylic dianhydride&gt; CBDA: 1,2,3,4-cyclobutanetetracarboxylic dianhydride TDA: 3,4-dicarboxy-1,2,3,4-tetrahydro-1-naphthalene Succinic dianhydride &lt;diamine&gt; 2- DABFr: 3,5-diaminobenzylfuran-2-carboxylate FrDAB: furan-2-ylmethyl 3,5-diaminobenzoate DAAFr: N-(3,5-diaminophenyl)furan-2-carboxamide DABTh: 3,5-diaminobenzylthiophene-2-carboxylate MeDABFr: 3,5-diaminobenzyl 5--5-methylfuran-2-carboxylate 3- DABFr3,5-diaminobenzylfuran-3-carboxylate Me4APhA: 4-amino-N-methylphenethylamine p-PDA: p -phenylenediamine DDM: 4,4'-diaminodiphenylmethane C14DAB: 4-tetradecyl-1,3-diaminobenzene C16DAB: 4-hexadecyl-1,3-diamine Benzene 3-ABA: 3-aminobenzylamine &lt;organic solvent&gt; NMP: N-methyl-2·pyrrolidone γ-ΒΙ^: γ-butyrolactone BC: butyl-cellosolve DPM: dipropylene glycol monomethyl ether 201030056 DMF: dimethylformamide &lt;Measurement of molecular weight&gt; The molecular weight of polylysine or polyimine obtained by polymerization is by GPC (normal temperature gel permeation chromatography) device, and polyethylene The diol and polyethylene oxides are converted to 値, and the number average molecular weight is calculated. An average molecular weight. _ GPC device: manufactured by Shodex Co., Ltd. (GPC-101) Pipe column: Shodex pipe column (inline of KD-803, KD-805)

管柱溫度:5 0 °C 溶離液:N,N’-二甲基甲醯胺(添加劑爲溴化鋰-水合物 (LiBr*H20)爲 30mmol/L,憐酸.無水結晶(〇-憐酸)爲 30mmol/L,四氫呋喃(THF)爲 l〇ml/L) 流速:1.0ml/分鐘 校正曲線製作用標準樣品:東曹公司製 TSK標準聚 〇 乙烯氧化物(分子量約 900,000、150,000、100,000、 3 0,000)及聚合物LABORATORY公司製聚乙二醇(分子量 約 12,000、 4,000、 1,000) 〇 &lt;醯亞胺化率之測定&gt; 化學醯亞胺化所得之聚醯亞胺的醯亞胺化率係將聚醯 亞胺溶解於d6-DMSO(二甲基亞颯-d6)中,測定W-NMR, 由質子譜峰累積値之比計算得到未醯亞胺化而殘存之醯胺 酸基的比率。 -43- 201030056 &lt;液晶胞之製作&gt; 以實施例及比較例調製的液晶配向處理劑,藉由下述 方式製作液晶胞。 將液晶配向處理劑旋轉塗佈於附有透明電極之玻璃基 板上,在70°C之加熱板上乾燥70秒後,在210°C之加熱 板上進行燒成1〇分鐘’形成膜厚l〇〇nm的塗膜。以輥徑 12 0mm之摩擦裝置,使用人造絲布在輥轉數l〇〇〇rpm、輥 _ 行進速度50mm/sec、押入量〇.3mm的條件下摩擦該塗膜 面,得到附有液晶配向膜的基板。準備2片附有液晶配向 膜的基板,其中1片的液晶配向膜面上散佈的間隔 物後,由上面印刷密封劑,使另1片的基板在液晶配向膜 面相對向,摩擦方向直交的狀態予以貼合後,使密封劑硬 化製作空晶胞。此空晶胞藉由減壓注入法注入液晶MLC-2003(Merck公司製),將注入口封閉得到扭轉向列型液晶 胞。 〇 製作後之各液晶胞之物性測定及特性評價的方法如下 述。 實施例1〜9、及比較例1 ~ 3中之各液晶配向處理劑之 組成、各液晶配向膜之物性測定及特性評價等的結果如表 2、表3所示。 &lt;摩擦耐性評價&gt; 以上述之 &lt;液晶胞之製作 &gt;所記載的方法製作附液晶配 -44 - 201030056 向膜的基板。此時摩擦條件之押入量改爲〇.5mm。所得之 液晶配向膜表面以共焦點雷射顯微鏡觀察,進行以下評 價。 〇:未觀察到切硝渣或摩擦損傷。 △:觀察到切硝渣或摩擦損傷。 X:膜產生剝離或以目視觀察到摩擦損傷。 Φ 〈液晶配向性評價&gt; 爲了區別液晶配向性之優劣,因此製作以下的液晶 胞。將液晶配向處理劑旋轉塗佈於附有透明電極之玻璃基 板上,在70°c之加熱板上乾燥70秒後,在210°c之加熱 板上進行燒成10分鐘,形成膜厚100nm的塗膜。以輥徑 12 0mm之摩擦裝置,使用人造絲布在輥轉數10 〇〇rpm、輥 行進速度50mm/SeC、押入量0.2mm的條件下摩擦該塗膜 面,得到附有液晶配向膜的基板。準備2片附有液晶配向 〇 膜的基板,其中1片的液晶配向膜面上散佈6μιη的間隔 物後,由上面印刷密封劑,使另1片的基板在液晶配向膜 面相對向,摩擦方向成爲1 8 0 °的狀態予以貼合後,使密 封劑硬化製作空晶胞。此空晶胞藉由減壓注入法注入液晶 MLC-2 00 3(MerCk公司製),將注入口封閉得到反平行液晶 胞。以目視觀察該液晶胞的初期配向。如下述評價。結果 如後述的表2所示。 〇:良好配向。 X:觀察到許多漏光或配向不良處。 -45- 201030056 &lt;預傾角測定&gt; 以上述之 &lt;液晶胞之製作 &gt;所記載的方法製作的扭轉向 列型液晶胞以105 °C加熱5分鐘後,測定預傾角與電壓保 持率。預傾角係使用晶體旋轉法(crystal rotation method) 測定。 &lt;電壓保持率之測定&gt; 以上述之 &lt;液晶胞之製作 &gt;所記載的方法製作之扭轉向 列型液晶胞之電壓保持率之測定係在90°C之溫度下,在 6Ops間施加4V的電壓,測定16.67ms後的電壓,而電壓 可保持多少程度,此以作爲電壓保持率來計算。電壓保持 率之測定係使用東陽Technic公司製之VHR-1電壓保持率 測定裝置。 &lt;蓄積電荷(RDC)之評估&gt; 以上述之 &lt;液晶胞之製作 &gt;所記載的方法製作之扭轉向 列型液晶胞,在23°C之溫度下,以〇V〜0.1V間隔施加直 流電壓至1.0V爲止,測定各電壓之閃爍(flicker)振幅水 平,製作校正曲線。5分鐘間接地後,施加交流電壓 3.0V、直流電壓5.0V,1小時後,測定僅直流電壓爲〇V 後之閃爍振幅水平,藉由與預先製作之校正曲線對照,預 估RDC。(此RDC之預估方法稱爲閃爍參照法) -46 - 201030056 (實施例l) 四羧酸二酐成分爲使用CBDA 5.00g(0.025mol)、二胺 成分爲使用 2-DABFr 6.03g(0.026mol) ’ 在 NMP 44.14g 中,室溫下反應16小時,得到聚醯胺酸(PA A-1)之濃度 20質量%的溶液。將聚醯胺酸(PAA-1)溶液l〇.〇g使用 NMP 23.3g及BC lO.Og稀釋,得到聚醯胺酸(PAA-1)爲 4.6質量%之液晶配向處理劑。使用此液晶配向處理劑進 φ 行摩擦耐性、預傾角、電壓保持率(VHR)、及RDC之評 價。結果如表2所示。 (實施例2) 在與實施例1同樣得到之聚醯胺酸(PAA-1)溶液 (PAA-1濃度20質量%)408中,添加NMP 9 3.3 3 g稀釋, 然後再添加乙酸酐5.7 7 g與吡啶2 · 3 9 g,以4 0 °C反應3小 時進行醯亞胺化。將此反應溶液冷卻至室溫程度後,投入 〇 於甲醇500ml中,回收沈澱的固形物。再將此固形物使用 甲醇2次洗淨後,以100°C減壓乾燥得到聚醯亞胺(SPI-1) 之白色粉末。此聚醯亞胺之數平均分子量爲13,2 04、重量 平均分子量爲30,700。醯亞胺化率爲87%。 所得之聚醯亞胺(SPI-l)2.00g中添加γ-BL 18.0g,以 50 °C攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。 再於此溶液中添加γ-BL 8.0g、BC 6.00g及DPM 6.00g, 以50°C攪拌20小時,得到聚醯亞胺(SPI-1)爲5質量%的 液晶配向處理劑。使用此液晶配向處理劑與實施例1同樣 -47- 201030056 評價。結果如表2所示。 (實施例3) 四羧酸二酐成分爲使用CBD A 5.52 g(〇. 02 8 mol)、二胺 成分爲使用 2-DABFr2.00g(0.009mol)、3-ABA l_40g (0.01 1 mol) ' 及 C14DAB 2 · 7 6 g (0 · 0 0 9 m ο 1),在 NMP46.7g 中,室溫下反應16小時,得到聚醯胺酸(PA A-2)之濃度 2〇質量%的溶液。此聚醯胺酸(PAA-2)溶液l〇.〇g使用 NMP23.3g、及BClO.Og稀釋,得到聚醯胺酸(P A A-2)爲 4 · 6質量%的液晶配向處理劑。使用此液晶配向處理劑與 實施例1同樣評價。結果如表2所示。 (實施例4) 在與實施例3同樣所得之聚醯胺酸(P A A-2)溶液(P A A-2濃度20質量%)4 0.08中,添加\1^?93.38稀釋,然後再 添加乙酸酐6.02g與吡啶2.49g,以60°C反應3小時進行 © 醯亞胺化。將此反應溶液冷卻至室溫程度後,投入於甲醇 5 00ml中,回收沈澱的固形物。再將此固形物使用甲醇2 次洗淨後,以l〇〇°C減壓乾燥得到聚醯亞胺(SPI-2)之白色 粉末。此聚醯亞胺之數平均分子量爲15,850、重量平均分 子量爲42,234。醯亞胺化率爲92%。 此聚醯亞胺(SPI-2)2.00g中添加γ-BL 18.0g,以50°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加 γ-BL 8_00g、BC 6.00g 及 DPM 6.00g,以 -48- 201030056 50t攪拌20小時,得到聚醯亞胺(SPI-2)爲5質量%的液 晶配向處理劑。使用此液晶配向處理劑與實施例1同樣評 價。結果如表2所示。 (實施例5) 四羧酸二酐成分爲使用CBDA 5.57g(0,029mol)、二胺 成分爲使用 FrDAB 2.02g(0.009mol)、3-ABA 1.42g (0.012mol)、及 C14DAB 2.79g(0.009mol),在 NMP46.7g 中,室溫下反應16小時,得到聚醯胺酸(PAA-3)之濃度 20質量%的溶液。 此聚醯胺酸(PAA-3)溶液 lO.Og使用 NMP23.3g、及 BClO.Og稀釋,得到聚醯胺酸(PAA-3)爲4.6質量%的溶 液,得到本發明之液晶配向處理劑。使用此塗佈液,與實 施例1同樣評價。結果如表2所示。 φ (實施例6) 在與實施例5同樣所得之聚醯胺酸(PAA-3)溶液(PAA-3濃度20質量%)40.Og中,添加NMP 93.3g稀釋,然後再 添加乙酸酐6_06g與吡啶2.53g,以60°C反應3小時進行 醯亞胺化。將此反應溶液冷卻至室溫程度後,投入於甲醇 5 0 0ml中,回收沈澱的固形物。再將此固形物使用甲醇2 次洗淨後,以l〇〇°C減壓乾燥得到聚醯亞胺(SPI-3)之白茶 色粉末。此聚醯亞胺之數平均分子量爲17,920、重量平均 分子量爲41,29 0。醯亞胺化率爲89%。 -49- 201030056 此聚醯亞胺(SPI-3)2.00g中添加γ-BL 18.0g,以50°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加 γ-BL 8.00g、BC 6.00g 及 DPM 6.00g,以 50°C攪拌20小時,得到聚醯亞胺(SPI-3)爲5質量%的液 晶配向處理劑。使用此液晶配向處理劑與實施例1同樣評 價。結果如表2所示。 (實施例7) 四羧酸二酐成分爲使用CBDA 5.57g(〇.〇29mol)、二胺 成分爲使用 DAAFr l_89g(0.009mol)、3-ABA 1.42g (0.012mol)、及 C14DAB 2.79g(0.009mol),在 NMP46.7g 中’室溫下反應16小時,得到聚醯胺酸(PAA-4)之濃度 2〇質量%的溶液。此聚醯胺酸(PAA-4)溶液 l〇.〇g使用 NMP23.3g、及BClO.Og稀釋,得到聚醯胺酸(PA A-4)爲 4.6質量%的溶液,得到本發明之液晶配向處理劑。使用 此塗佈液,與實施例1同樣評價。結果如表2所示。 (實施例8) 在與實施例7同樣所得之聚醯胺酸(PAA-4)溶液(PAA-4濃度20質量%)40.(^中,添加NMP 93.3g稀釋,然後再 添加乙酸酐6 · 0 6 g與吡啶2 · 5 3 g,以6 0 °C反應3小時進行 醯亞胺化。將此反應溶液冷卻至室溫程度後,投入於甲醇 5 00ml中,回收沈澱的固形物。再將此固形物使用甲醇2 次洗淨後,以lOOt減壓乾燥得到聚醯亞胺(SPI-4)之白茶 201030056 色粉末。此聚醯亞胺之數平均分子量爲15,367、重量平均 分子量爲39,880。醯亞胺化率爲90%。 此聚醯亞胺(SPI-4)2.00g中添加γ-BL 18.0g,以50°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加 γ-BL 8.00g、BC 6.00g 及 DPM 6.00g,以 50°C攪拌20小時,得到聚醯亞胺(SPI-4)爲5質量%的液 晶配向處理劑。使用此液晶配向處理劑與實施例1同樣評 φ 價。結果如表2所示。 (實施例9) 四羧酸二酐成分爲使用TDA 12.0g(0.040m〇l)、二胺 成分爲使用 P-PDA 2.59g(0.024mol)、2-DABFr2.79g (0.012mol)、及 C 1 6DAB 1.39g(0.004mol),在 NMP75.7g 中,以5〇°C反應24小時,得到聚醯胺酸之濃度20質量% 的溶液。 Φ 此聚醯胺酸溶液90.0g中添加NMP 187g稀釋,再添 加乙酸酐3 9 · 6 g與吡啶1 8.4 g,以4 0 °C反應3小時進行醯 亞胺化。 將此反應溶液冷卻至室溫程度後,投入於甲醇1.17L 中,回收沈澱的固形物。再將此固形物使用甲醇2次洗淨 後,以l〇〇°C減壓乾燥得到聚醯亞胺(SPI-5)之白色粉末。 此聚醯亞胺之數平均分子量爲15,322、重量平均分子量爲 28,239。醯亞胺化率爲81%。Column temperature: 50 °C Dissolution: N,N'-dimethylformamide (additive lithium bromide-hydrate (LiBr*H20) is 30mmol/L, pity acid. Anhydrous crystal (〇-pity) It is 30 mmol/L, tetrahydrofuran (THF) is l〇ml/L) Flow rate: 1.0 ml/min Calibration curve Preparation Standard sample: TSK standard polystyrene ethylene oxide manufactured by Tosoh Corporation (molecular weight: about 900,000, 150,000, 100,000, 3 0,000) and polymer polyethylene glycol manufactured by LABORATORY Co., Ltd. (molecular weight: about 12,000, 4,000, 1,000) 〇 &lt;Measurement of sulfhydrylation rate&gt; 醯imination rate of polyimine obtained by chemical imidization The polyimine was dissolved in d6-DMSO (dimethyl sulfonium-d6), and W-NMR was measured. The ratio of the peaks of proton peaks was calculated to obtain the proline group remaining without imidization. ratio. -43-201030056 &lt;Production of liquid crystal cell&gt; The liquid crystal cell was produced in the following manner by the liquid crystal alignment treatment agent prepared in the examples and the comparative examples. The liquid crystal alignment treatment agent was spin-coated on a glass substrate with a transparent electrode, dried on a hot plate at 70 ° C for 70 seconds, and then fired on a hot plate at 210 ° C for 1 minute to form a film thickness. 〇〇nm coating film. The surface of the coating film was rubbed with a rayon cloth at a roller diameter of 120 mm using a rayon cloth at a number of revolutions of 100 rpm, a roller _ travel speed of 50 mm/sec, and a pushing amount of 3.3 mm to obtain a liquid crystal alignment. The substrate of the film. Preparing two substrates with a liquid crystal alignment film, wherein one of the liquid crystal alignment films is spread on the surface of the film, and then the sealant is printed on the upper surface, so that the other substrate is opposed to the liquid crystal alignment film surface, and the rubbing direction is orthogonal. After the state is applied, the sealant is hardened to form an empty unit cell. This empty cell was injected into a liquid crystal MLC-2003 (manufactured by Merck) by a pressure reduction injection method, and the injection port was closed to obtain a twisted nematic liquid crystal cell.方法 The method for measuring the physical properties and the property evaluation of each liquid crystal cell after production is as follows. Tables 2 and 3 show the results of the composition of each of the liquid crystal alignment treatment agents, the physical property measurement and the characteristic evaluation of each of the liquid crystal alignment films in Examples 1 to 9 and Comparative Examples 1 to 3. &lt;Evaluation of Friction Resistance&gt; A substrate having a liquid crystal-44 - 201030056 film was produced by the method described in the above &lt;Production of Liquid Crystal Cell&gt;. At this time, the amount of the friction condition was changed to 〇.5 mm. The surface of the obtained liquid crystal alignment film was observed by a confocal laser microscope, and the following evaluation was carried out. 〇: No cut slag or friction damage was observed. △: Cut slag or friction damage was observed. X: The film was peeled off or the frictional damage was visually observed. Φ <Liquid alignment evaluation> In order to distinguish the advantages and disadvantages of the liquid crystal alignment, the following liquid crystal cells were produced. The liquid crystal alignment treatment agent was spin-coated on a glass substrate with a transparent electrode, dried on a hot plate at 70° C. for 70 seconds, and then fired on a hot plate at 210° C. for 10 minutes to form a film thickness of 100 nm. Coating film. The surface of the coating film was rubbed with a rayon cloth at a roller rotation speed of 10 mm rpm, a roller traveling speed of 50 mm/SeC, and a pushing amount of 0.2 mm to obtain a substrate with a liquid crystal alignment film. . Two substrates with a liquid crystal alignment film are prepared, and a spacer of 6 μm is dispersed on one liquid crystal alignment film surface, and then a sealant is printed thereon to cause the other substrate to face in the liquid crystal alignment film surface, rubbing direction After bonding to a state of 180 °, the sealant is cured to form an empty cell. This empty cell was injected into a liquid crystal MLC-2 00 3 (manufactured by MerCk) by a pressure reduction injection method, and the injection port was closed to obtain an antiparallel liquid crystal cell. The initial alignment of the liquid crystal cell was visually observed. As evaluated below. The results are shown in Table 2 to be described later. 〇: Good alignment. X: A lot of light leakage or poor alignment was observed. -45-201030056 &lt;Pretilt angle measurement&gt; The twisted nematic liquid crystal cell produced by the method described in the above &lt;Production of liquid crystal cell&gt; was heated at 105 ° C for 5 minutes, and then the pretilt angle and voltage holding ratio were measured. . The pretilt angle was measured using a crystal rotation method. &lt;Measurement of Voltage Retention Rate&gt; The measurement of the voltage holding ratio of the twisted nematic liquid crystal cell produced by the method described in the above &lt;Production of Liquid Crystal Cell&gt; is at a temperature of 90 ° C, at 60 ° C A voltage of 4 V was applied, and the voltage after 16.67 ms was measured, and how much the voltage was maintained, which was calculated as the voltage holding ratio. The voltage holding ratio was measured by using a VHR-1 voltage holding ratio measuring device manufactured by Dongyang Technic Co., Ltd. &lt;Evaluation of Accumulated Charge (RDC)&gt; The twisted nematic liquid crystal cell produced by the method described in the above &lt;Production of Liquid Crystal Cell&gt; is separated by 〇V to 0.1 V at a temperature of 23 °C. A DC voltage was applied to 1.0 V, and the flicker amplitude level of each voltage was measured to prepare a calibration curve. After 5 minutes indirectly, an alternating voltage of 3.0 V and a direct current voltage of 5.0 V were applied, and after one hour, the flicker amplitude level after only the direct current voltage was 〇V was measured, and the RDC was estimated by comparison with a calibration curve prepared in advance. (This RDC estimation method is called scintillation reference method) -46 - 201030056 (Example 1) The tetracarboxylic dianhydride component is CBDA 5.00 g (0.025 mol), and the diamine component is 2-DABFr 6.03 g (0.026). Mol) 'In NMP 44.14g, the reaction was carried out for 16 hours at room temperature to obtain a solution having a polyamine acid (PA A-1) concentration of 20% by mass. The polyperuric acid (PAA-1) solution was diluted with NMP 23.3 g and BC 10·Og to obtain a liquid crystal alignment treatment agent having a polyamine acid (PAA-1) of 4.6% by mass. Using this liquid crystal alignment agent, φ was evaluated for friction resistance, pretilt angle, voltage holding ratio (VHR), and RDC. The results are shown in Table 2. (Example 2) In a polyacrylic acid (PAA-1) solution (PAA-1 concentration: 20% by mass) 408 obtained in the same manner as in Example 1, NMP 9 3.3 3 3 was added, followed by addition of acetic anhydride 5.7 7 . g and pyridine 2 · 3 9 g were reacted at 40 ° C for 3 hours to carry out hydrazine imidization. After the reaction solution was cooled to room temperature, it was poured into 500 ml of methanol to recover a precipitated solid. Further, the solid matter was washed twice with methanol, and then dried under reduced pressure at 100 ° C to obtain a white powder of polyethylenimine (SPI-1). The polyimine had a number average molecular weight of 13,2,04 and a weight average molecular weight of 30,700. The sulfhydrylation rate was 87%. 18.0 g of γ-BL was added to 2.00 g of the obtained polyimine (SPI-1), and the mixture was stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, 8.0 g of γ-BL, 6.00 g of BC, and 6.00 g of DPM were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a liquid crystal alignment treatment agent having a polyamidolimine (SPI-1) of 5% by mass. The liquid crystal alignment treatment agent was used in the same manner as in Example 1 -47-201030056. The results are shown in Table 2. (Example 3) The tetracarboxylic dianhydride component was obtained by using CBD A 5.52 g (〇. 02 8 mol), and the diamine component was 2-DABFr 2.00 g (0.009 mol) and 3-ABA l_40 g (0.01 1 mol). And C14DAB 2 · 7 6 g (0 · 0 0 9 m ο 1), reacted in NMP 46.7g at room temperature for 16 hours to obtain a solution of polyamine acid (PA A-2) at a concentration of 2 〇 mass % . This poly-proline (PAA-2) solution was diluted with NMP 23.3 g and BClO.Og to obtain a liquid crystal alignment treatment agent having a polyamic acid (P A A-2) of 4.6 mass%. This liquid crystal alignment treatment agent was evaluated in the same manner as in Example 1. The results are shown in Table 2. (Example 4) In a polyacrylic acid (PA A-2) solution (PA A-2 concentration: 20% by mass) 4 0.08 obtained in the same manner as in Example 3, a dilution of \1^?93.38 was added, and then B was added. 6.02 g of an acid anhydride and 2.49 g of pyridine were reacted at 60 ° C for 3 hours to carry out hydrazylation. After the reaction solution was cooled to room temperature, it was poured into 500 ml of methanol to recover a precipitated solid. Further, the solid matter was washed twice with methanol, and then dried under reduced pressure at 10 ° C to obtain a white powder of polyethylenimine (SPI-2). The polyimine had a number average molecular weight of 15,850 and a weight average molecular weight of 42,234. The sulfhydrylation rate was 92%. 18.0 g of γ-BL was added to 2.00 g of this polyimine (SPI-2), and the mixture was stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 8_00 g, BC 6.00 g, and DPM 6.00 g were added to the solution, and the mixture was stirred at -48 - 201030056 50t for 20 hours to obtain a liquid crystal alignment treatment agent having a polyamidolimine (SPI-2) of 5% by mass. This liquid crystal alignment treatment agent was evaluated in the same manner as in Example 1. The results are shown in Table 2. (Example 5) The tetracarboxylic dianhydride component was 5.57 g (0,029 mol) using CBDA, and the diamine component was 2.0 g (0.009 mol) of FrDAB, 1.42 g (0.012 mol) of 3-ABA, and 2.79 g (0.009) of C14DAB. Mol) was reacted at room temperature for 16 hours in NMP 46.7 g to obtain a solution having a polyamine acid (PAA-3) concentration of 20% by mass. The polyacrylic acid (PAA-3) solution was diluted with NMP 23.3 g and BClO.Og to obtain a solution of polyamine acid (PAA-3) of 4.6% by mass to obtain a liquid crystal alignment treatment agent of the present invention. . The coating liquid was used and evaluated in the same manner as in Example 1. The results are shown in Table 2. φ (Example 6) In a 40.Og solution of a polyacrylic acid (PAA-3) solution (PAA-3 concentration: 20% by mass) obtained in the same manner as in Example 5, 93.3 g of NMP was added and diluted, and then acetic anhydride 6_06 g was further added. The ruthenium imidization was carried out by reacting with pyridine 2.53 g at 60 ° C for 3 hours. After the reaction solution was cooled to room temperature, it was poured into methanol (500 ml), and the precipitated solid was collected. Further, this solid matter was washed twice with methanol, and then dried under reduced pressure at 10 ° C to obtain a white tan powder of polyimine (SPI-3). The polyimine had a number average molecular weight of 17,920 and a weight average molecular weight of 41,290. The hydrazine imidation rate was 89%. -49- 201030056 18.0 g of γ-BL was added to 2.00 g of this polyimine (SPI-3), and the mixture was stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 8.00 g, BC 6.00 g, and DPM 6.00 g were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a liquid crystal alignment treatment agent of 5 mass % of polyimine (SPI-3). This liquid crystal alignment treatment agent was evaluated in the same manner as in Example 1. The results are shown in Table 2. (Example 7) The tetracarboxylic dianhydride component was 5.57 g (〇.〇29 mol) of CBDA, and DAAFr l_89g (0.009 mol), 3-ABA 1.42 g (0.012 mol), and C14DAB 2.79 g of the diamine component. 0.009 mol), reacted at room temperature for 16 hours in NMP 46.7 g to obtain a solution of polyamine acid (PAA-4) at a concentration of 2% by mass. The polyaminic acid (PAA-4) solution was diluted with NMP 23.3 g and BClO.Og to obtain a solution of polyamine acid (PA A-4) of 4.6% by mass to obtain a liquid crystal of the present invention. Orientation treatment agent. This coating liquid was used in the same manner as in Example 1. The results are shown in Table 2. (Example 8) A polylysine (PAA-4) solution (PAA-4 concentration: 20% by mass) obtained in the same manner as in Example 7 was used. (In addition, NMP 93.3 g was added and diluted, and then acetic anhydride 6 was further added. 0 6 g and pyridine 2 · 5 3 g were reacted at 60 ° C for 3 hours to carry out hydrazine imidization. The reaction solution was cooled to room temperature, and then poured into methanol (500 ml) to recover a precipitated solid. The solid matter was washed twice with methanol, and dried under reduced pressure at 100 Torr to obtain a white tea 201030056 color powder of polyimine (SPI-4). The number average molecular weight of the polyimine was 15,367, and the weight average molecular weight was 39,880. The yield of ruthenium was 90%. 18.0 g of γ-BL was added to 2.00 g of this polyimine (SPI-4), and the mixture was stirred at 50 ° C for 20 hours. At the end of the stirring, the polyimine was completely dissolved. Further, γ-BL 8.00 g, BC 6.00 g, and DPM 6.00 g were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a liquid crystal alignment treatment agent having a polyamidimide (SPI-4) of 5% by mass. The liquid crystal alignment treatment agent was evaluated in the same manner as in Example 1. The results are shown in Table 2. (Example 9) The tetracarboxylic dianhydride component was TDA 12.0 g (0.040 m〇l). The diamine component was 2.59 g (0.024 mol) of P-PDA, 2.79 g (0.012 mol) of 2-DABFr, and 1.39 g (0.004 mol) of C 16 6DAB, and reacted at 5 ° C in NMP 75.7 g. In an hour, a solution having a concentration of polyamic acid of 20% by mass is obtained. Φ 90.0 g of this polyaminic acid solution is diluted with 187 g of NMP, and then added with acetic anhydride 3 9 · 6 g and pyridine 1 8.4 g at 40 ° C After reacting for 3 hours, the reaction solution was cooled to room temperature, and then poured into 1.17 L of methanol to recover the precipitated solid matter. The solid matter was washed twice with methanol, and then washed. The white powder of polyimine (SPI-5) was obtained by drying under reduced pressure at ° C. The number average molecular weight of this polyimine was 15,322, and the weight average molecular weight was 28,239. The oxime imidization ratio was 81%.

此聚醯亞胺(SPI-5)5.00g中添加γ-BL 62.5g,以50°C -51 - 201030056 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加γ-BL 2〇.8g,以5〇°C攪拌20小時,得到聚 醯亞胺(SPI-5)爲5.7質量%的溶液。 另外,將 CBDA 9.80g(0.050mol)、PMDA 9.60g (0.0 4 4 m ο 1)、D D Μ 1 9 · 8 g (0 · 1 0 m ο 1),在 Ν Μ P 1 1 1 g 與 γ-BLlllg之混合溶劑中,以室溫反應5小時,調製聚醯胺 酸(PAA-5)之濃度15質量%的溶液。此聚醯胺酸係數平均 分子量爲10,925,重量平均分子量爲27,314。 此聚醯胺酸(PAA-5)溶液200g中添加γ-BL 225g、及 BC 75.0g,以室溫攪拌2小時,得到聚醯胺酸(PAA-5)爲 6質量%的溶液。將此聚醯胺酸(PAA-5)之6質量%溶液 200g與上述所得之聚醯亞胺(SPI-5)之6質量%溶液50.0g 在室溫下攪拌20小時後,固形分(PAA-5與SPI-5之合計 質量濃度)調整爲5.9質量%,得到本發明之液晶配向處理 劑(B L -1)。使用此液晶配向處理劑,與實施例1同樣評 價。結果如表2所示。 (實施例10) 四羧酸二酐成分爲使用CBDA 5.7 8g(0.029mol) ’二胺 成分使用 DABTh 2.24g(0.009mol)、3-AB A 1 .47g (0.012mol)、及 C14DAB 2 · 8 9 g( 0.0 0 9 m ο 1),在 NMP44.96g 中,以室溫反應16小時得到20質量%之聚醯胺酸溶液 (P A A - 6) 〇 將聚醯胺酸溶液(PAA-6) 10.0g使用 NMP23.3g、 201030056 BC10.0g稀釋,形成固形分爲4.6質量%的溶液’得到本 發明之液晶配向處理劑。使用此塗佈液與實施例1同樣評 價。結果如表2所不。 (實施例1 1) 在與實施例10同樣所得之聚醯胺酸(PAA-6)溶液 (PAA-6濃度20質量%)40g中’添加NMP 93.33g稀釋’ ❿ 然後再添加乙酸酐5.61g與吡啶2.32g ’以60°C反應3小 時進行醯亞胺化。將此反應溶液冷卻至室溫程度後’投入 於甲醇500ml中,回收沈澱的固形物。再將此固形物使用 甲醇數次洗淨後,以1〇〇 °C減壓乾燥得到聚醯亞胺(SP 1-6) 之白色粉末。此聚醯亞胺之數平均分子量爲13,163'重量 平均分子量爲30,211。醯亞胺化率爲85%。 此聚醯亞胺(SPI-7)2.00g中添加γ-BL 18.0g’以50°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 φ 此溶液中添加 γ-BL 8.0g、BC 6.00g 及 DPM 6.00g,以 50°C攪拌20小時,得到聚醯亞胺(SPI-6)爲5質量%的溶 液,得到本發明之液晶配向處理劑。使用此塗佈液與實施 例1同樣評價。結果如表2所示。 (實施例12) 四羧酸二酐成分爲使用CBDA 5.57g(0.029mol),二胺 成分使用 M eD AB F r 2.1 4 g( 0 · 0 0 9 mo 1)、3 - A B A 1 · 4 2 g (0.012mol)、及 C14DAB 2.7 9 g (0.0 0 9m o 1) &gt; 在 NMP46.7g -53- 201030056 中,以室溫反應16小時,得到聚醯胺酸(pa A-7)之濃度 20質量%的溶液。 此聚醯胺酸(PAA-7)溶液i〇.〇g使用NMP23.3g、及 BClO.Og稀釋,形成聚醯胺酸(PAA-7)爲4.6質量%的溶 液,得到本發明之液晶配向處理劑。使用此塗佈液進行與 實施例1同樣評價。結果如表2所示。 (實施例13) 在與實施例1〇同樣所得之聚醯胺酸(PAA-7)溶液 (PAA-7濃度20質量%)4(^中,添加NMP 93.3g稀釋,然 後再添加乙酸酐6.0 6 g與吡啶2 · 5 3 g,以6 0 °C反應3小時 進行醯亞胺化。將此反應溶液冷卻至室溫程度後,投入於 甲醇500ml中,回收沈澱的固形物。再將此固形物使用甲 醇2次洗淨後’以100°C減壓乾燥得到聚醯亞胺(SPI-7)之 白茶色粉末。此聚醯亞胺之數平均分子量爲15.787、重量 平均分子量爲3 6.43 3。醯亞胺化率爲87%。 此聚醯亞胺(SPI-7)2.00g中添加γ-BL 18.0g,以5〇°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加 γ-BL 8.00g、BC 6.00g 及 DPM 6.00g,以 50°C攪拌20小時,得到聚醯亞胺(SPI-7)爲5質量%的溶 液,得到本發明之液晶配向處理劑。使用此塗佈液與實施 例1同樣評價。結果如表2所示。 (實施例14) 201030056 四羧酸二酐成分爲使用CBDA 5.57g(0.029mol),二胺 成分使用 3-DABFr 2.02g(0.009mol) ' 3-ABA 1.42g (0.012mol)、及 C14DAB 2 · 7 9 g( 0.0 0 9 m ο 1),在 NMP46.7g 中,以室溫反應16小時,得到聚醯胺酸(PAA-8)之濃度 2 0質量%的溶液。 此聚醯胺酸(PAA-8)溶液lO.Og使用NMP23.3g、及 BClO.Og稀釋形成聚醯胺酸(PAA-8)爲4.6質量%的溶液, φ 得到本發明之液晶配向處理劑。使用此塗佈液進行與實施 例1同樣的評價。結果如表2所示。 (實施例15) 在與實施例14同樣所得之聚醯胺酸(PAA-8)溶液 (PAA-8濃度20質量%)40.(^中,添加NMP 93.3g稀釋, 然後再添加乙酸酐6.06g與吡啶2.53g,以60°C反應3小 時進行醯亞胺化。將此反應溶液冷卻至室溫程度後,投入 〇 於甲醇500ml中,回收沈澱的固形物。再將此固形物使用 甲醇2次洗淨後,以100°C減壓乾燥得到聚醯亞胺(SPI-8) 之白茶色粉末。此聚醯亞胺之數平均分子量爲16,142、重 量平均分子量爲3 8,5 74 »醯亞胺化率爲89%。 此聚醯亞胺(SPI-8)2.00g中添加γ-BL 18.0g,以50°C 攪拌20小時。攪拌終了時點,聚醯亞胺完全溶解。再於 此溶液中添加 γ-BL 8.00g、BC 6_00g 及 DPM 6.00g,以 5(TC攪拌20小時,得到聚醯亞胺(SPI-8)爲5質量%的液 晶配向處理劑。使用此液晶配向處理劑與實施例1同樣評 -55- 201030056 價。結果如表2所示。 四羧酸二酐成分爲使用CBDA 5.57g(0.02 9mol),二胺 成分使用 2-DABFr 2.02g(0.009mol)、及 Me4APhA 3.05g (0.021mol),在NMP46.7g中,以室溫反應16小時,得到 聚醯胺酸(PAA-9)之濃度20質量%的溶液。此聚醯胺酸之 數平均分子量係2 1,329、重量平均分子量係45,2 94。 將此聚醯胺酸(PAA-9)溶液lO.Og使用NMP 23.3g、 及BC lO.Og稀釋,形成聚醯胺酸(PAA-9)爲4.6質量%的 溶液,得到本發明之液晶配向處理劑。使用此塗佈液進行 與實施例1同樣的評價。結果如表2所示。 (比較例1) 四羧酸二酐成分爲使用CBDA 12.5g(0_064mol),二胺 成分使用 3-ABA 5.56g(0_046mol)、及 C14DAB 6.25g (0.020mol),在NMP97.20g中,以室溫反應16小時,得 到聚醯胺酸(PAA-10)之濃度20質量%的溶液。 〇 此聚醯胺酸(PAA-10)的溶液lO.Og使用NMP23.3g、 及BClO.Og稀釋,形成聚醯胺酸(PAA-10)之濃度爲4.6質 量%的溶液,得到作爲比較對象的液晶配向處理劑。使用 此塗佈液進行與實施例1同樣製作液晶胞,進行物性之測 定、特性之評價。 (比較例2) 在與比較例1同樣所得之聚醯胺酸(PAA-10)溶液 -56- 201030056 (PAA-10 濃度 20 質量 %)50g 中,添加 NMP 116.67g 稀 釋,再添加乙酸酐7.39g與吡啶3.15g,以70°C反應3小 時,進行醯亞胺化,但是反應中產生凝膠化。 再次,於與比較例1同樣所得之聚醯胺酸(PAA-10)溶 液(PAA-10濃度20質量%)50g中,添加NMP 116.67g稀 釋,再添加乙酸酐7.39g與吡啶3.15g,以反應溫度50°C 的條件,進行醯亞胺化。 φ 將此反應溶液冷卻至室溫程度後,投入於甲醇250ml 中,回收沈澱的固形物。再將此固形物使用甲醇2次洗淨 後,以lOOt減壓乾燥得到聚醯亞胺(SPI-9)之白色粉末。 此聚醯亞胺之數平均分子量爲1 6,3 3 8、重量平均分子量爲 39,865。醯亞胺化率爲80%。 此聚醯亞胺(SPI-9)lg中添加γ-BL 9g,以50°C攪拌 20小時。攪拌終了時點,聚醯亞胺完全溶解。再於此溶 液中添加 γ-BL 4.0g、BC 3.0g 及 DPM 3.0g,以 50°C 攪拌 Φ 20小時,得到聚醯亞胺(SPI-9)爲5質量%的溶液,得到作 爲比較對象的液晶配向處理劑。使用此液晶配向處理劑進 行與實施例1同樣製作液晶胞,進行物性之測定、特性之 評價。 (比較例3) 四羧酸二酐成分爲使用CBDA 5.70g(0.029mol),二胺 成分使用 Me4APhA 4 · 5 1 g (0 · 0 3 0m ο 1),在 N MP 4 6.7 g 中, 以室溫反應16小時得到聚醯胺酸(PAA-1 1)之濃度20質量 -57- 201030056 %的溶液。此聚醯胺酸之數平均分子量爲1 9,630、重量2P 均分子量爲48,201。 此聚醯胺酸(PAA-11)溶液lO.Og使用NMP23.3g、及 BC lO.Og稀釋,形成聚醯胺酸(PAA-11)爲4.6質量%的溶 液,得到作爲比較對象之液晶配向處理劑。使用此液晶配 向處理劑與實施例1同樣製作液晶胞,進行物性之測定、 特性之評價。To the 5.00 g of this polyimine (SPI-5), 62.5 g of γ-BL was added, and the mixture was stirred at 50 ° C -51 - 201030056 for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 2 〇.8 g was added to the solution, and the mixture was stirred at 5 ° C for 20 hours to obtain a solution of 5.7% by mass of polyimine (SPI-5). In addition, CBDA 9.80g (0.050mol), PMDA 9.60g (0.0 4 4 m ο 1), DD Μ 1 9 · 8 g (0 · 1 0 m ο 1), in Ν Μ P 1 1 1 g and γ In a mixed solvent of -BLlllg, the solution was reacted at room temperature for 5 hours to prepare a solution having a concentration of polyamine acid (PAA-5) of 15% by mass. The polyamido acid coefficient had an average molecular weight of 10,925 and a weight average molecular weight of 27,314. To 200 g of this polyaminic acid (PAA-5) solution, 225 g of γ-BL and 75.0 g of BC were added, and the mixture was stirred at room temperature for 2 hours to obtain a solution of polyamine acid (PAA-5) of 6 mass%. 200 g of a 6 mass% solution of the polyamic acid (PAA-5) and 50.0 g of a 6 mass% solution of the polyimine (SPI-5) obtained above were stirred at room temperature for 20 hours, and then solid content (PAA) The total mass concentration of -5 and SPI-5 was adjusted to 5.9% by mass to obtain a liquid crystal alignment treatment agent (BL-1) of the present invention. This liquid crystal alignment treatment agent was used in the same manner as in Example 1. The results are shown in Table 2. (Example 10) The tetracarboxylic dianhydride component was CBDA 5.7 8 g (0.029 mol) 'diamine component using DABTh 2.24 g (0.009 mol), 3-AB A 1.47 g (0.012 mol), and C14DAB 2 · 8 9 g (0.0 0 9 m ο 1), in NMP 44.96g, reacted at room temperature for 16 hours to obtain 20% by mass of poly-proline solution (PAA-6). Poly-proline solution (PAA-6) 10.0 g was diluted with NMP 23.3 g and 201030056 BC 10.0 g to form a solution having a solid content of 4.6 mass%, and the liquid crystal alignment treatment agent of the present invention was obtained. This coating liquid was used in the same manner as in Example 1. The results are shown in Table 2. (Example 1 1) In a 40 g of polyacrylic acid (PAA-6) solution (PAA-6 concentration: 20% by mass) obtained in the same manner as in Example 10, 'addition of NMP 93.33 g of dilution' ❿ followed by addition of acetic anhydride 5.61 g The ruthenium imidization was carried out by reacting with pyridine 2.32 g ' at 60 ° C for 3 hours. The reaction solution was cooled to room temperature and then poured into 500 ml of methanol to recover the precipitated solid. Further, the solid matter was washed with methanol several times, and then dried under reduced pressure at 1 ° C to obtain a white powder of polyethylenimine (SP 1-6). The polyimine had a number average molecular weight of 13,163' weight and an average molecular weight of 30,211. The hydrazine imidation rate was 85%. To the 2.00 g of this polyimine (SPI-7), γ-BL 18.0 g' was added and stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 8.0 g, BC 6.00 g, and DPM 6.00 g were added to the solution of φ, and the mixture was stirred at 50° C. for 20 hours to obtain a solution of 5 mass % of polyimine (SPI-6) to obtain the present invention. Liquid crystal alignment treatment agent. This coating liquid was used in the same manner as in Example 1. The results are shown in Table 2. (Example 12) The tetracarboxylic dianhydride component was 5.57 g (0.029 mol) using CBDA, and the e amine component was M eD AB F r 2.1 4 g (0 · 0 9 mo 1), 3 - ABA 1 · 4 2 g (0.012 mol), and C14DAB 2.7 9 g (0.0 0 9m o 1) &gt; In NMP46.7g -53- 201030056, reacted at room temperature for 16 hours to obtain the concentration of poly-proline (pa A-7) 20% by mass solution. The polyaminic acid (PAA-7) solution was diluted with NMP 23.3 g and BClO.Og to form a solution of polyamine acid (PAA-7) of 4.6% by mass to obtain the liquid crystal alignment of the present invention. Treatment agent. The same evaluation as in Example 1 was carried out using this coating liquid. The results are shown in Table 2. (Example 13) A polyacrylic acid (PAA-7) solution (PAA-7 concentration: 20% by mass) 4 obtained in the same manner as in Example 1 was added, and NMP 93.3 g was added thereto, followed by addition of acetic anhydride 6.0. 6 g and pyridine 2 · 5 3 g were reacted at 60 ° C for 3 hours to carry out hydrazine imidization. After cooling the reaction solution to room temperature, it was poured into 500 ml of methanol to recover the precipitated solid matter. The solid matter was washed twice with methanol, and then dried under reduced pressure at 100 ° C to obtain a white tan powder of polyimine (SPI-7). The number average molecular weight of the polyimine was 15.787 and the weight average molecular weight was 3.43. 3. The imidization ratio of ruthenium was 87%. 18.0 g of γ-BL was added to 2.00 g of this polyimine (SPI-7), and stirred at 5 ° C for 20 hours. At the end of the stirring, the polyimine was completely dissolved. Further, γ-BL 8.00 g, BC 6.00 g, and DPM 6.00 g were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a solution of 5 % by mass of polyimine (SPI-7), thereby obtaining the present invention. The liquid crystal alignment treatment agent was used in the same manner as in Example 1. The results are shown in Table 2. (Example 14) 201030056 The tetracarboxylic dianhydride component was CBDA. 5.57g (0.029mol), diamine component using 3-DABFr 2.02g (0.009mol) ' 3-ABA 1.42g (0.012mol), and C14DAB 2 · 7 9 g (0.0 0 9 m ο 1), in NMP46. In 7 g, the reaction was carried out at room temperature for 16 hours to obtain a solution of polyamine acid (PAA-8) at a concentration of 20% by mass. The polyamine acid (PAA-8) solution was 10.3 g using NMP 23.3 g and BClO. The Og was diluted to form a solution of polyamine acid (PAA-8) of 4.6% by mass, and φ was obtained to obtain a liquid crystal alignment treatment agent of the present invention. The same evaluation as in Example 1 was carried out using the coating liquid. (Example 15) A polylysine (PAA-8) solution (PAA-8 concentration: 20% by mass) obtained in the same manner as in Example 14 was used. (In addition, NMP 93.3 g was added and diluted, and then acetic anhydride was further added. 6.06 g and 2.53 g of pyridine were reacted at 60 ° C for 3 hours to carry out hydrazine imidization. After cooling the reaction solution to room temperature, it was poured into 500 ml of methanol to recover the precipitated solid matter. After washing with methanol twice, it was dried under reduced pressure at 100 ° C to obtain a white tan powder of polyimine (SPI-8) having a number average molecular weight of 16,142 and a weight average molecular weight. 8,5 3 74 »acyl imidization was 89%. This polyimide (SPI-8) in the γ-BL 18.0g was added 2.00g, stirred at 50 ° C 20 h. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 8.00 g, BC 6_00 g, and DPM 6.00 g were added to the solution, and 5 (TC was stirred for 20 hours to obtain a liquid crystal alignment treatment agent having a polyamidimide (SPI-8) of 5% by mass. The alignment treatment agent was evaluated in the same manner as in Example 1 at -55-201030056. The results are shown in Table 2. The tetracarboxylic dianhydride component was 5.57 g (0.02 9 mol) using CBDA, and 2-DABFr 2.02 g (0.009 mol) was used as the diamine component. And Me4APhA 3.05g (0.021mol), and reacted at room temperature for 16 hours in NMP46.7g to obtain a solution of polyglycine (PAA-9) at a concentration of 20% by mass. The molecular weight is 2 1,329, and the weight average molecular weight is 45, 2 94. The polyamine acid (PAA-9) solution of 10.Og is diluted with NMP 23.3g and BC 10 .Og to form poly-proline (PAA-9). The liquid crystal alignment treatment agent of the present invention was obtained in a solution of 4.6% by mass. The same evaluation as in Example 1 was carried out using the coating liquid. The results are shown in Table 2. (Comparative Example 1) The tetracarboxylic dianhydride component was Using CBDA 12.5g (0_064mol), the diamine component used 3-ABA 5.56g (0_046mol), and C14DAB 6.25g (0.020mol), in NMP97.20g, at room temperature After 16 hours, a solution of 20% by mass of polyglycine (PAA-10) was obtained. The solution of polylysine (PAA-10) was diluted with NMP 23.3 g and BClO.Og to form a poly A solution having a concentration of lysine (PAA-10) of 4.6% by mass was obtained, and a liquid crystal alignment treatment agent to be compared was obtained. Using this coating liquid, liquid crystal cells were produced in the same manner as in Example 1, and physical properties were measured and evaluated. (Comparative Example 2) In 50 g of polyacrylic acid (PAA-10) solution-56-201030056 (PAA-10 concentration: 20% by mass) obtained in the same manner as in Comparative Example 1, 116.67 g of NMP was added and diluted, and then acetic anhydride was added. 7.39 g and 3.15 g of pyridine were reacted at 70 ° C for 3 hours to carry out hydrazine imidation, but gelation occurred in the reaction. Again, the polylysine (PAA-10) solution obtained in the same manner as in Comparative Example 1 ( In 50 g of PAA-10 concentration, 50 g of NMP was added and diluted with 116.67 g of NMP, and then 7.37 g of acetic anhydride and 3.15 g of pyridine were added, and hydrazylation was carried out at a reaction temperature of 50 ° C. φ The reaction solution was cooled to After being at room temperature, it is poured into 250 ml of methanol to recover the precipitated solid matter. After washing with methanol twice, it was dried under reduced pressure at 100 Torr to give a white powder of polyethylenimine (SPI-9). The polyimine had a number average molecular weight of 1,6,33.8 and a weight average molecular weight of 39,865. The hydrazine imidation rate is 80%. To the poly-imine (SPI-9) lg, 9 g of γ-BL was added, and the mixture was stirred at 50 ° C for 20 hours. At the end of the agitation, the polyimine was completely dissolved. Further, γ-BL 4.0 g, BC 3.0 g, and DPM 3.0 g were added to the solution, and the mixture was stirred at 50 ° C for 20 hours to obtain a solution of 5 mass % of polyimine (SPI-9), which was obtained as a comparison object. Liquid crystal alignment treatment agent. Using the liquid crystal alignment agent, liquid crystal cells were produced in the same manner as in Example 1, and physical properties were measured and evaluated. (Comparative Example 3) The tetracarboxylic dianhydride component was 5.70 g (0.029 mol) using CBDA, and Me4APhA 4 · 5 1 g (0 · 0 3 0 m ο 1 ) was used as the diamine component in N MP 4 6.7 g The reaction was carried out at room temperature for 16 hours to obtain a solution of polyglycine (PAA-1 1) at a concentration of 20 mass - 57 - 201030056 %. The polyammonic acid had a number average molecular weight of 1,9,630 and a weight 2P average molecular weight of 48,201. The polyamine acid (PAA-11) solution was diluted with NMP 23.3 g and BC 10 ·Og to form a solution of polyamine acid (PAA-11) of 4.6% by mass, and the liquid crystal alignment was obtained as a comparison object. Treatment agent. A liquid crystal cell was produced in the same manner as in Example 1 using this liquid crystal alignment treatment agent, and physical properties were measured and properties were evaluated.

-58- 201030056 [表1]-58- 201030056 [Table 1]

聚醯胺酸或 聚醯亞胺 醢亞胺化率 [%] 酸二酐 二胺成分 PAA-1 — CBDA(0.025) 2-DABFr (0.026) PAA-2 — CBDA (0.028) 3-ABA (0.011), 2-DABFr (0. 009), C14DAB (0. 009) PAA-3 — CBDA (0.029) 3-ABA(0.012), FrDAB(0.009), C14DAB (0. 009) PAA-4 — CBDA (0.029) 3-ABA (0.012), DAAFr (0.009), C14DAB (0. 009) PAA-5 — CBDA (0.050) PMDA (0.044) DDM(0. 10) PAA-6 — CBDA (0.029) 3-ABA(0.012),DABTh(0.009), C14DAB (0. 009) PAA-7 — CBDA (0.029) 3-ABA(0.012),MeDABFr(0. 009), C14DAB (0. 009) PAA-8 — CBDA (0. 029) 3-ABA (0. 012), 3-DABFr (0. 009), C14DAB (0. 009) PAA-9 — CBDA (0.029) Me4APhA (〇. 021), 2-DABFr (0. 009) PAA-10 — CBDA (0. 064) 3-ABA(0. 046), C14DAB (0. 020) PAA-11 — CBDA (0.029) Me4APhA (0.030) SPI-1 87 CBDA (0.025) 2-DABFr (0. 026) SP1-2 92 CBDA (0.028) 3-ABA (0.011), 2-DABFr (0. 009), C14DAB (0. 009) SPI-3 89 CBDA (0. 029) 3-ABA (0. 012), FrDAB (0.009), C14DAB (0. 009) SPI-4 90 CBDA (0.029) 3-ABA(0.012), DAAFr (0.009), C14DAB (0. 009) SPI-5 81 TDA(0. 040) p-PDA (0. 024), 2-DABFr (0.012). Cl 6DAB (0. 004) SPI-6 85 CBDA (0.029) 3-ABA (0.012), DABTh (0.009), C14DAB (0.009) SPI-7 87 CBDA (0.029) 3-ABA (0. 012), MeDABFr (〇. 009), C14DAB (0. 009) SPI-8 89 CBDA (0.029) 3-ABA(0. 012), 3-DABFr (0. 009), C14DAB (0. 009) SPI-9 80 CBDA (0.064) 3-ABA (0. 046), C14DAB (0. 020) -59- 201030056 〔表2〕 聚醯胺酸或聚醯亞胺 [質量比] 液晶 配向性 摩擦耐性 傾斜角 0 電壓保持率 (%) RDC m 實施例1 ΡΑΑ-1 〇 〇 1.0 93 0.26 實施例2 SPI-1 〇 〇 1.2 95 0.22 實施例3 ΡΑΑ-2 〇 〇 6.2 94 0.20 實施例4 SPI-2 〇 〇 4.1 96 0.11 實施例5 ΡΑΑ-3 〇 〇 4.8 92 0.22 實施例ό SPI-3 〇 〇 3.8 94 0.12 實施例7 ΡΑΑ-4 〇 〇 5.5 94 0.19 實施例8 SPI-4 〇 〇 4.1 96 0.10 實施例9 PAA-5/SPI-5(8/2) 〇 〇 3.1 92 0.18 實施例10 PAA-6 〇 〇 6.0 93 0.20 實施例11 SPI-6 〇 〇 4.3 94 0.15 實施例12 PAA-7 〇 〇 6.2 92 0.22 實施例13 SPI-7 〇 〇 4.1 95 0.13 實施例14 PAA-8 〇 〇 6.1 93 0.20 實施例15 SPI-8 〇 〇 4.0 94 0.12 實施例16 PAA-9 〇 〇 1.0 96 0.25 比較例1 PAA-10 〇 Δ 4.5 87 0.50 比較例2 SPI-9 〇 X 3.1 92 0.45 比較例3 PAA-11 〇 X 1.2 92 0.88 [產業上之利用性] 藉由本發明之液晶配向處理劑,可得到對於摩擦時之 膜剝離或切削耐性強,電壓保持率高,且即使對液晶胞施 加直流電壓,也不易產生初期電荷之蓄積之液晶配向膜的 液晶配向處理劑。因此,使用本發明之液晶配向處理劑製 作的液晶顯示元件可成爲信賴性較高的液晶顯示裝置,非 -60- 201030056 常適用於TN液晶顯示元件、STN液晶顯示元件、TFT液 晶顯示元件、VA液晶顯示元件、IPS液晶顯示元件、 OCB液晶顯示元件等,以各種方式所產生的顯示元件。 於茲引用2008年10月17日申請之曰本專利申請案 2〇〇8-26〇486號之說明書、申請專利範圍及發明摘要之全 部內容’作爲本發明之說明書。Polyamide or polyamidiamine oxime iodization rate [%] acid dianhydride diamine component PAA-1 — CBDA (0.025) 2-DABFr (0.026) PAA-2 — CBDA (0.028) 3-ABA (0.011 ), 2-DABFr (0. 009), C14DAB (0. 009) PAA-3 — CBDA (0.029) 3-ABA(0.012), FrDAB(0.009), C14DAB (0. 009) PAA-4 — CBDA (0.029 ) 3-ABA (0.012), DAAFr (0.009), C14DAB (0. 009) PAA-5 — CBDA (0.050) PMDA (0.044) DDM (0. 10) PAA-6 — CBDA (0.029) 3-ABA (0.012 ), DABTh(0.009), C14DAB (0. 009) PAA-7 — CBDA (0.029) 3-ABA(0.012), MeDABFr(0. 009), C14DAB (0. 009) PAA-8 — CBDA (0. 029 ) 3-ABA (0. 012), 3-DABFr (0. 009), C14DAB (0. 009) PAA-9 — CBDA (0.029) Me4APhA (〇. 021), 2-DABFr (0. 009) PAA- 10 — CBDA (0. 064) 3-ABA(0. 046), C14DAB (0. 020) PAA-11 — CBDA (0.029) Me4APhA (0.030) SPI-1 87 CBDA (0.025) 2-DABFr (0. 026 SP1-2 92 CBDA (0.028) 3-ABA (0.011), 2-DABFr (0. 009), C14DAB (0. 009) SPI-3 89 CBDA (0. 029) 3-ABA (0. 012), FrDAB (0.009), C14DAB (0. 009) SPI-4 90 CBDA (0.029) 3-ABA(0.012), DAAFr (0.009), C14DAB (0. 009) SPI-5 8 1 TDA(0. 040) p-PDA (0. 024), 2-DABFr (0.012). Cl 6DAB (0. 004) SPI-6 85 CBDA (0.029) 3-ABA (0.012), DABTh (0.009), C14DAB (0.009) SPI-7 87 CBDA (0.029) 3-ABA (0. 012), MeDABFr (〇. 009), C14DAB (0. 009) SPI-8 89 CBDA (0.029) 3-ABA (0. 012) , 3-DABFr (0. 009), C14DAB (0. 009) SPI-9 80 CBDA (0.064) 3-ABA (0. 046), C14DAB (0. 020) -59- 201030056 [Table 2] Polyamide Acid or polyimine [mass ratio] Liquid crystal alignment frictional resistance tilt angle 0 Voltage retention ratio (%) RDC m Example 1 ΡΑΑ-1 〇〇1.0 93 0.26 Example 2 SPI-1 〇〇1.2 95 0.22 Example 3 ΡΑΑ-2 〇〇6.2 94 0.20 Example 4 SPI-2 〇〇4.1 96 0.11 Example 5 ΡΑΑ-3 〇〇4.8 92 0.22 Example ό SPI-3 〇〇3.8 94 0.12 Example 7 ΡΑΑ-4 〇〇 5.5 94 0.19 Example 8 SPI-4 〇〇4.1 96 0.10 Example 9 PAA-5/SPI-5(8/2) 〇〇3.1 92 0.18 Example 10 PAA-6 〇〇6.0 93 0.20 Example 11 SPI- 6 〇〇 4.3 94 0.15 Example 12 PAA-7 〇〇 6.2 92 0.22 Example 13 SPI-7 〇〇 4.1 95 0.13 Example 14 PAA-8 〇〇6.1 93 0.20 Example 15 SPI-8 〇〇4.0 94 0.12 Example 16 PAA-9 〇〇1.0 96 0.25 Comparative Example 1 PAA-10 〇Δ 4.5 87 0.50 Comparative Example 2 SPI-9 〇X 3.1 92 0.45 Comparative Example 3 PAA-11 〇X 1.2 92 0.88 [Industrial Applicability] With the liquid crystal alignment treatment agent of the present invention, film peeling or cutting resistance during rubbing can be obtained, and the voltage holding ratio is high, and even When a DC voltage is applied to the liquid crystal cell, the liquid crystal alignment agent of the liquid crystal alignment film in which the initial charge is accumulated is less likely to occur. Therefore, the liquid crystal display element produced by using the liquid crystal alignment treatment agent of the present invention can be a highly reliable liquid crystal display device, and non-60-201030056 is often applied to a TN liquid crystal display element, an STN liquid crystal display element, a TFT liquid crystal display element, and a VA. A display element produced in various ways, such as a liquid crystal display element, an IPS liquid crystal display element, an OCB liquid crystal display element, or the like. The entire contents of the specification, the scope of the patent application and the summary of the disclosure of the patent application No.

Claims (1)

201030056 七、申請專利範園 1. 一種液晶配向處理劑,其特徵係含有選自使含有 下述式[1]之二胺的二胺成分與四羧酸二酐成分反應所得 之聚醯胺酸、及使該聚醯胺酸進行醯亞胺化所得的聚醯亞 胺所成群之至少一種的聚合物, [化1] h2n 、、 nh2201030056 VII. Patent application garden 1. A liquid crystal alignment treatment agent characterized in that it comprises a polyamine acid obtained by reacting a diamine component containing a diamine of the following formula [1] with a tetracarboxylic dianhydride component. And a polymer of at least one of a group of polyimine obtained by subjecting the polyamic acid to ruthenium imidation, [Chem. 1] h2n, nh2 (式中,X係表示單鍵、碳數爲1〜3之伸烷基、-OCH2- ' -CH20C0-、-NHCO-、-CONH-、或-COOCH2-,Y 係表示氧原子或硫原子,五員環之任意的氫原子可被碳數 1〜5之烷基取代)。 2.如申請專利範圍第1項之液晶配向處理劑,其中 式Π]之γ爲氧原子。 3 .如申請專利範圍第1項之液晶配向處理劑,其中 0 式[1]之γ爲硫原子。 4·如申請專利範圍第1~3項中任一項之液晶配向處 理劑’其中式[1]之 X爲-CH2OCO-、-NHCO-、或· cooch2-。 5·如申請專利範圍第1項之液晶配向處理劑,其中 式[Π之 X 爲- CH2〇CO-、-NHCO-、或- COOCH2-,Y 爲氧 原子。 6·如申請專利範圍第1 ~5項中任一項之液晶配向處 -62- 201030056 理劑’其中式[1]之五員環之任意的氫原子被甲基取代。 7. —種液晶配向膜’其特徵係使用申請專利範圍第 1 ~6項中任一項之液晶配向處理劑所得者。 8 · —種液晶顯示元件’其特徵係具備申請專利範圍 第7項之液晶配向膜。 9. 一種二胺,其特徵係以下述式[2]表示, [化2](wherein X represents a single bond, an alkylene group having a carbon number of 1 to 3, -OCH2-'-CH20C0-, -NHCO-, -CONH-, or -COOCH2-, and Y represents an oxygen atom or a sulfur atom. Any hydrogen atom of the five-membered ring may be substituted by an alkyl group having 1 to 5 carbon atoms). 2. The liquid crystal alignment treatment agent of claim 1, wherein γ of the formula 为 is an oxygen atom. 3. The liquid crystal alignment treatment agent of claim 1, wherein γ of the formula [1] is a sulfur atom. 4. The liquid crystal alignment treatment agent according to any one of claims 1 to 3 wherein X of the formula [1] is -CH2OCO-, -NHCO-, or · cooch2-. 5. The liquid crystal alignment treatment agent of claim 1, wherein X is -CH2〇CO-, -NHCO-, or -COOCH2-, Y is an oxygen atom. 6. Liquid crystal alignment as claimed in any one of claims 1 to 5 - 62 - 201030056 Physical agent ' Any hydrogen atom of the five-membered ring of the formula [1] is substituted with a methyl group. 7. A liquid crystal alignment film which is obtained by using the liquid crystal alignment treatment agent according to any one of claims 1 to 6. A liquid crystal display element is characterized in that it has the liquid crystal alignment film of claim 7 of the patent application. A diamine characterized by the following formula [2], [Chemical 2] (呋喃環之任意的氫原子可被碳數1〜5的烷基取代)。 10. 如申請專利範圍第9項之二胺,其中呋喃環之任 意的氫原子可被甲基取代。 11. 一種聚醯亞胺,其特徵係使含有申請專利範圍第 φ 9或10項之二胺的二胺成分與四羧酸二酐成分反應所得 之聚醯胺酸、或將該聚醯胺酸進行醯亞胺化所得。 201030056 四、指定代表圖: (一) 、本案指定代表圖為:無 (二) 、本代表圖之元件符號簡單說明:無(Any hydrogen atom of the furan ring may be substituted by an alkyl group having 1 to 5 carbon atoms). 10. The diamine of claim 9, wherein any of the hydrogen atoms of the furan ring may be substituted by a methyl group. A polyimine which is characterized in that the polyamine contained in a diamine component containing a diamine of the claim φ 9 or 10 and a tetracarboxylic dianhydride component are obtained, or the polyamine The acid is obtained by hydrazine imidization. 201030056 IV. Designated representative map: (1) The designated representative figure of this case is: None (2), the symbol of the representative figure is simple: no 201030056 五 本案若有化學式時,請揭示最能顯示發明特徵的化學 式:無201030056 V If there is a chemical formula in this case, please reveal the chemical formula that best shows the characteristics of the invention: none -4 --4 -
TW098133968A 2008-10-07 2009-10-07 A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device TWI454504B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008260486 2008-10-07

Publications (2)

Publication Number Publication Date
TW201030056A true TW201030056A (en) 2010-08-16
TWI454504B TWI454504B (en) 2014-10-01

Family

ID=42100615

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098133968A TWI454504B (en) 2008-10-07 2009-10-07 A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device

Country Status (5)

Country Link
JP (2) JP5333453B2 (en)
KR (1) KR101613753B1 (en)
CN (2) CN103641805B (en)
TW (1) TWI454504B (en)
WO (1) WO2010041665A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI640574B (en) * 2016-02-25 2018-11-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI666232B (en) * 2016-06-04 2019-07-21 奇美實業股份有限公司 Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9164326B2 (en) 2010-08-03 2015-10-20 Sharp Kabushiki Kaisha Liquid crystal display device and process for producing liquid crystal display device
US9195097B2 (en) 2010-08-03 2015-11-24 Sharp Kabushiki Kaisha Liquid crystal display device and process for producing liquid-crystal display device
US9164325B2 (en) 2010-08-03 2015-10-20 Sharp Kabushiki Kaisha Liquid crystal display device and process for producing liquid crystal display device
CN103080824B (en) 2010-09-07 2016-03-09 夏普株式会社 Liquid crystal layer forms the manufacture method with composition, liquid crystal indicator and liquid crystal indicator
WO2012077668A1 (en) 2010-12-06 2012-06-14 シャープ株式会社 Liquid crystal display device and method for producing liquid crystal display device
WO2012086715A1 (en) 2010-12-22 2012-06-28 シャープ株式会社 Liquid crystal orienting agent, lcd device, and method for producing lcd device
CN116444793A (en) * 2023-03-22 2023-07-18 青岛达亿星电子化工新材料研究院有限公司 High-performance polyimide flexible copper-clad plate and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100414697B1 (en) * 1999-01-25 2004-01-13 리카가쿠 겐큐쇼 Photosensitive resin composition and semiconductor apparatus using the same
JP4258690B2 (en) * 1999-05-26 2009-04-30 独立行政法人理化学研究所 Photosensitive resin composition
JP3942063B2 (en) 1999-06-28 2007-07-11 株式会社カネカ Novel polyimide composition and novel acid dianhydride used in the same
TW565582B (en) * 2001-04-13 2003-12-11 Kaneka Corp Diamine, acid dianhydride, and reactive group containing polyimide composition prepared therefrom and preparing them
US7193030B2 (en) * 2003-06-18 2007-03-20 Mitsubishi Gas Chemical Company, Inc. Acid anhydride and polyimide using the same
CN100400529C (en) * 2003-10-08 2008-07-09 中国科学院化学研究所 Fluoro-aromatic organic tetracarboxylic dianhydride and its preparation method and use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI640574B (en) * 2016-02-25 2018-11-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI666232B (en) * 2016-06-04 2019-07-21 奇美實業股份有限公司 Liquid crystal alignment agent and production method thereof, liquid crystal alignment film and production method thereof, and liquid crystal display element

Also Published As

Publication number Publication date
JP5660160B2 (en) 2015-01-28
CN103641805A (en) 2014-03-19
CN102171604B (en) 2014-05-14
KR101613753B1 (en) 2016-04-19
TWI454504B (en) 2014-10-01
JPWO2010041665A1 (en) 2012-03-08
JP5333453B2 (en) 2013-11-06
CN103641805B (en) 2015-08-19
CN102171604A (en) 2011-08-31
JP2013231041A (en) 2013-11-14
KR20110066161A (en) 2011-06-16
WO2010041665A1 (en) 2010-04-15

Similar Documents

Publication Publication Date Title
TWI485181B (en) A liquid crystal alignment agent and a liquid crystal display device using the same, and novel diamine
JP4840137B2 (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element using the same
JP6152914B2 (en) Novel dicarboxylic acid anhydride and process for producing the same
TWI454504B (en) A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device
TWI429617B (en) Diamine compounds, polyamic acid, polyimide and liquid crystal alignment treatment agent
TWI675067B (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal display element, polymer, diamine, and tetracarboxylic dianhydride
TW200948860A (en) Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element
TWI502054B (en) A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device
TWI504675B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
KR101492656B1 (en) Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent
TWI526419B (en) Novel diamine, polymer, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device using the same
TWI436980B (en) Diamine, polyimide precursor, polyimide, liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element
TW200944553A (en) Liquid-crystal alignment material and liquid-crystal display element
TW201211108A (en) Liquid crystal aligning agent, liquid crystal alignment film produced using same, and liquid crystal display element
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI461462B (en) A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device
TWI819102B (en) Liquid crystal alignment agent, liquid crystal alignment film, liquid crystal element and manufacturing method thereof
TW201502202A (en) Liquid crystal orientation agent, liquid crystal orientation membrane, and liquid crystal display element using same
TWI596201B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI510520B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TW201934663A (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal element
KR101894831B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device